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ABSTRACT We developed a new approach that couples Southwestern blotting and
mass spectrometry to discover proteins that bind extracellular DNA (eDNA) in bacte-
rial biofilms. Using Staphylococcus aureus as a model pathogen, we identified pro-
teins with known DNA-binding activity and uncovered a series of lipoproteins with
previously unrecognized DNA-binding activity. We demonstrated that expression of
these lipoproteins results in an eDNA-dependent biofilm enhancement. Additionally,
we found that while deletion of lipoproteins had a minimal impact on biofilm accu-
mulation, these lipoprotein mutations increased biofilm porosity, suggesting that li-
poproteins and their associated interactions contribute to biofilm structure. For one
of the lipoproteins, SaeP, we showed that the biofilm phenotype requires the lipo-
protein to be anchored to the outside of the cellular membrane, and we further
showed that increased SaeP expression correlates with more retention of high-
molecular-weight DNA on the bacterial cell surface. SaeP is a known auxiliary pro-
tein of the SaeRS system, and we also demonstrated that the levels of SaeP corre-
late with nuclease production, which can further impact biofilm development. It has
been reported that S. aureus biofilms are stabilized by positively charged cytoplas-
mic proteins that are released into the extracellular environment, where they make
favorable electrostatic interactions with the negatively charged cell surface and
eDNA. In this work we extend this electrostatic net model to include secreted eDNA-
binding proteins and membrane-attached lipoproteins that can function as anchor
points between eDNA in the biofilm matrix and the bacterial cell surface.
IMPORTANCE Many bacteria are capable of forming biofilms encased in a matrix of
self-produced extracellular polymeric substances (EPS) that protects them from che-
motherapies and the host defenses. As a result of these inherent resistance mecha-
nisms, bacterial biofilms are extremely difficult to eradicate and are associated with
chronic wounds, orthopedic and surgical wound infections, and invasive infections,
such as infective endocarditis and osteomyelitis. It is therefore important to under-
stand the nature of the interactions between the bacterial cell surface and EPS that
stabilize biofilms. Extracellular DNA (eDNA) has been recognized as an EPS constitu-
ent for many bacterial species and has been shown to be important in promoting
biofilm formation. Using Staphylococcus aureus biofilms, we show that membrane-
attached lipoproteins can interact with the eDNA in the biofilm matrix and promote
biofilm formation, which suggests that lipoproteins are potential targets for novel
therapies aimed at disrupting bacterial biofilms.
KEYWORDS MRSA, Southwestern blotting, Staphylococcus aureus, biofilms, eDNA,
extracellular DNA, nuclease
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The capacity to form a biofilm is of fundamental importance in the ability of bacteriato cause chronic wounds, to infect indwelling medical devices, and to cause severe,
invasive diseases, such as osteomyelitis and endocarditis. The opportunistic pathogen
Staphylococcus aureus is particularly adept at forming biofilms, making it the most
commonly identified bacterial species in chronic wounds (1–3), the leading cause of
infective endocarditis (4, 5), the second most common causative agent in periprosthetic
orthopedic infections (6), and the most common cause of osteomyelitis (7). Once
attached to an implanted device or host tissue and growing within the extracellular
matrix (ECM) of a biofilm, S. aureus suppresses the host immune response (8, 9) and
becomes highly resistant to antibiotic chemotherapy (10), allowing for persistence
within the host. Given the recalcitrant nature of biofilm-associated infections, interven-
tions that target the biofilm matrix could offer therapeutic benefits (11). As such, the
exact nature of the biofilm matrix and the mechanisms by which individual bacteria
interact with and attach to matrix material are topics of recent interest.
The bacterial biofilm matrix, which typically accounts for 90% or more of the biofilm
dry weight, is crucial for maintaining hydration and the structural integrity of biofilms
(12, 13). Our understanding of what constitutes the ECM has evolved over decades,
such that it is now generally believed to consist of self-produced extracellular polymeric
substances (EPS) that fall within three primary categories: (i) exopolysaccharide, (ii)
extracellular and cell surface-associated proteins/adhesins, and (iii) extracellular DNA
(eDNA). The relative abundance of the macromolecules that fall within these three
classes of matrix constituents can vary depending on the bacterial species and the
conditions, such as the medium composition or shear stress (12, 13), under which the
biofilm was grown. In the case of S. aureus, our understanding of the contributions that
the classes of EPS components make to biofilm formation and maintenance is contin-
ually evolving, with the number and variety of macromolecules that fall within the
scope of EPS ever increasing.
The exopolysaccharide consisting of poly-b(1-6)-N-acetylglucosamine (PNAG), also
referred to as polysaccharide intercellular adhesin (PIA) (14, 15), was the first compo-
nent of S. aureus EPS to be identified. Recent atomic force microscopy studies (16)
indicate that positively charged PIA promotes cell-cell adhesion between S. aureus cells
via multivalent electrostatic interactions with polyanionic teichoic acids and lipo-
teichoic acids. Initially, PIA was thought to be essential for S. aureus biofilm formation,
but more recently, an increasing number of reports (reviewed in reference 14) have
demonstrated that biofilms can be made by strains lacking the ica locus, responsible for
PIA synthesis. The biofilms described in these reports are sensitive to proteases and
dependent on the presence of various cell wall-attached (CWA) proteins. Subsequently,
extensive and ongoing studies have shown that CWA proteins (reviewed in references
17 and 18) contribute to biofilm development by promoting the attachment of S.
aureus to host cells and tissues through specific interactions with host proteins, as well
as through self-association between individual cells.
Recent studies suggest that extracellular DNA (eDNA) may play a more significant
role than microbial surface components recognizing adhesive matrix molecules
(MSCRAMM) adhesin proteins when S. aureus forms biofilms on abiotic surfaces (19).
Using a microfluidic flow cell system, Moormeier and colleagues (19) found that mutant
strains that were deficient in the production of MSCRAMM proteins, including
fibronectin-binding proteins A and B (FnbA and FnbB) (20), extracellular matrix and
plasma binding protein (Empbp) (21), clumping factors A and B (ClfA and ClfB) (22, 23),
protein A (24), elastin-binding protein (EbpS) (25), Sas family proteins (26, 27), and
serine-aspartate repeat (Sdr) family proteins (28, 29), grew biofilms that were indistin-
guishable from those grown by the wild type (WT). Likewise, biofilm formation was
not altered in mutants deficient in PIA synthesis, consistent with the previous
finding that S. aureus strains of the USA300 lineage form an ica-independent biofilm
(30). In contrast, biofilm formation was reduced in the atlA mutant that lacks the
murine hydrolase AtlA, which had previously been shown to promote biofilm
formation by functioning as the autolysin responsible for the release of eDNA that
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incorporates into the matrix (31). Additionally, Moormeier et al. identified a new
phase of biofilm development, termed “exodus,” that is dependent on the SaeRS
regulatory system and staphylococcal nuclease (Nuc) activity, which again suggests
that eDNA plays a crucial role in early biofilm maturation (19, 32). It was also
observed that the addition of exogenous Nuc disrupted biofilm formation, but only
if exogenous nuclease was introduced during the exodus phase, raising the possi-
bility that eDNA may be protected from digestion by eDNA-binding proteins in
early developmental stages. Since deletion of MSCRAMM proteins failed to impact
biofilm development, the eDNA-binding proteins may belong to a protein class
other than the MSCRAMM proteins.
Recent reports from the Losick group suggest that recycled cytoplasmic proteins
may “moonlight” as biofilm matrix proteins that bind eDNA in the S. aureus biofilm (33,
34), potentially protecting the eDNA from digestion by Nuc or host DNase I. By
disrupting biofilms and suspending cells at various pHs, these cytoplasmic proteins
were found to be associated with the outside of cells through electrostatic interactions
(35). Treatment of biofilm cells with either proteinase K or DNase severely reduced the
ability of bacteria to form clumps, indicating that both proteins and eDNA contribute
to maintaining biofilm integrity (34). Importantly, addition of exogenous DNA to
DNase-treated cells, but not proteinase K-treated cells, restored clumping, highlighting
the importance of eDNA in forming interconnections between cells within the biofilm.
The authors proposed an electrostatic net model for the role of eDNA in biofilm
maintenance, in which negatively charged eDNA interacts with positively charged
cytoplasmic proteins released during cell autolysis. These cytoplasmic proteins in turn
interact with the negatively charged cell surface molecules, such as phospholipids and
teichoic acids. The model has recently been bolstered by a comprehensive mass
spectrophotometric analysis of the S. aureus intracellular, biofilm ECM, and biofilm
flowthrough proteomes (35), which found that the average pI of proteins within the
biofilm ECM was over pH 8 and significantly greater than the average pI of proteins
found in either the intracellular or flowthrough proteomes. Like the Losick group (33,
34), Graf and colleagues (35) found that the ECM contained cytoplasmic proteins in
abundance, but they also found that the ECM was highly populated with secreted
virulence factors and ribosomal proteins.
Here we report the results of a Southwestern (SW) blotting screen for eDNA-binding
proteins that complements and extends the electrostatic net model for S. aureus
biofilms. A combination of SW blotting and mass spectrometry (MS) approaches was
used to probe membranes for proteins with eDNA-binding activity. Proteins previously
known to possess DNA-binding activity (such as IsaB, Atl, and Eap) were identified, and
more importantly, previously unrecognized DNA-binding activity was discovered for a
number of membrane-associated proteins and membrane-anchored lipoproteins. We
also show that overexpression of identified eDNA-binding proteins results in increased
retention of surface eDNA, which correlates with enhanced biofilm biomass. For one of
the lipoproteins, SaeP, it was further demonstrated that the ability to enhance biofilm
formation was dependent on the protein being localized and attached to the extra-
cellular face of the cell membrane. Bioinformatic analysis identified additional lipopro-
teins with high pIs and potential DNA-binding activity, including lipoproteins belong-
ing to the conserved staphylococcal antigens (Csa) family. Importantly, deletion of the
Csa proteins increased the porosity of the biofilm, suggesting that membrane-attached
lipoproteins contribute to biofilm tortuosity. Collectively, our findings indicate that
eDNA-binding lipoproteins represent a previously unrecognized contributor to S. au-
reus biofilm formation by linking individual bacterial cells together through noncova-
lent cross-links with high-molecular-weight (high-MW) eDNA found within the matrix.
For SaeP, it was further demonstrated that the ability to enhance biofilm formation was
partly dependent on the inhibition of Nuc production, consistent with the role of SaeP
in modulating the activity of the SaeRS two-component system.
eDNA-Binding Proteins in the Biofilm Matrix ®











































Identification of potential eDNA-binding proteins. To better understand the
composition of the S. aureus biofilm matrix, we developed a screen based on South-
western (SW) blotting techniques, which are classically used to characterize protein-
DNA interactions. We adapted this technique to identify proteins isolated from the
biofilm matrix with nonspecific DNA-binding activity, as proteins with sequence-
specific DNA binding would be less likely to play a major biofilm structural role. To carry
out this experiment, the USA300 strain LAC was grown in planktonic and biofilm
cultures overnight (Fig. 1A). Cells were collected from these cultures and fractionated
to yield cellular membranes, since proteins associated with the membrane fraction
could potentially provide bridging interactions between the cell surface and matrix
components, such as eDNA. The cell membrane fraction was run on duplicate nonre-
ducing SDS-PAGE gels, and one gel was Coomassie stained for protein band visualiza-
tion (Fig. 1B, left). The remaining gel was treated with a Triton X-100-based buffer to
allow for protein refolding within the gel and then incubated with an IRD700-labeled
DNA probe (Fig. 1B, right). The gel images were then overlaid (Fig. 1B, center) to identify
bands on the Coomassie-stained gel with DNA-binding activity. The same procedure
was applied to the media from the planktonic and biofilm cultures (Fig. 1C) in order to
compare the results with those of membrane SW blotting, as we reasoned that the
media could potentially contain important eDNA-binding proteins. In total, 11 bands
FIG 1 SW blotting approach. (A) Schematic of the SW blotting experimental design. (B) SW analysis of membrane-associated proteins
prepared from planktonic and biofilm bacteria. The left panel, with red bands, is an image of the 700-nm scan of a Coomassie-stained
gel, and the far-right panel, with green bands, is an image of the 700-nm scan of a duplicate gel taken after the proteins were
renatured and the gel was probed with IRD700-labeled DNA. In the center panel, the IRD700-labeled DNA panel was overlaid on the
Coomassie-stained panel. Labels for the MW markers (in kilodaltons) are shown at the far left, and identification band numbers for the
bands that were excised and sent for MS analysis are shown at the far right. (C) SW analysis of soluble proteins in medium from
planktonic cultures and biofilms.
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(labeled bands 1 through 11 along the right edge of Fig. 1B and C) were excised and
sent for identification by MS analysis.
While the SW analysis utilized purified membranes, both the abbreviated (Table 1)
and complete (see Table S1 in the supplemental material) lists of the top protein
identifications returned by MS analysis included membrane proteins, cell wall-
associated proteins, secreted proteins, as well as cytoplasmic proteins, highlighting the
fact that it is not possible to completely resolve subcellular fractions from one another.
Presumably, the nonmembrane proteins that were identified are the ones with the
highest binding affinity for membrane components, which could include phospholip-
ids, membrane-attached or embedded proteins, and/or lipoteichoic acids, since these
proteins pelleted with membranes, while other proteins did not. Alternatively, the
nonmembrane proteins could have associated with eDNA, which in turn associated
with components of the membrane fraction. Of note, with the exception of band 6
(analysis failed to yield an identification), numerous proteins for each band were
identified as being present with 100% certainty. This presents a challenge in terms of
assigning responsibility for the IRD700-DNA bands to any particular protein or set of
proteins, which will be addressed in more detail below. Overall, there was very good
agreement between the list in Table S1 and the results of the proteome analysis
recently published by Graf et al. (35), as indicated by the positions of the proteins within
the rank order of abundance in the ECM. Of significance, the majority of the membrane
fraction proteins in the list were found by Graf et al. (35) to have high fold changes
when comparing their abundance in ECM relative to that in the biofilm flowthrough
(see the FC [fold change] ECM/FT [flowthrough] column in Table S1), meaning that once
TABLE 1 Representative hits from SW analysis screen
Protein source





1 SAUSA300_1917 Eap, extracellular adherence protein Secreted membrane associated 65.7 9.9
1 SAUSA300_0955 AtlA amidase domain Surface, equatorial ring 60.8 9.6
1 SAUSA300_1193 Aerobic glycerol-3-
phosphate dehydrogenase
Cytoplasmic 62.4 7.0
2 SAUSA300_1790 PrsA peptidyl-prolyl cis-trans isomerase Membrane lipoprotein 35.6 9.0
2 SAUSA300_0618 ABC transporter, Mn/Zn transporter
substrate-binding protein
Membrane protein 34.7 8.7
2 SAUSA300_0419 Lpl lipoprotein Membrane lipoprotein 31.4 8.8
3 SAUSA300_2201 RplA, 50S ribosomal protein L1 Cytoplasmic/ribosome 30.1 10.7
4 SAUSA300_2142 Asp23 Cytoplasmic 20.3 8.2
4 SAUSA300_2187 RpsE, 30S ribosomal protein S5 Cytoplasmic/ribosome 17.7 9.9
4 SAUSA300_0079 CopL lipoprotein Membrane lipoprotein 20.1 9.0
5 SAUSA300_0605 SarA Cytoplasmic 14.7 8.1
5 SAUSA300_0693 SaeP Membrane lipoprotein 16.0 9.1
5 SAUSA300_2573 IsaB Cytoplasmic 19.4 9.7
Spent
medium
7 SAUSA300_0955 AtlA, full length Surface, equatorial ring 116.5 9.6
8 SAUSA300_0320 Geh, triacylglycerol lipase Secreted 72.2 9.0
8 SAUSA300_0955 AtlA amidase domain Surface equatorial ring 60.8 9.6
8 SAUSA300_2579 N-Acetylmuramoyl-L-
alanine amidase
Surface, equatorial ring 69.2 6.4
9 SAUSA300_0703 LtaS, SpsB-liberated domain Surface, equatorial ring 49.3 8.6
9 SAUSA300_0955 AtlA glucosaminidase domain Surface, equatorial ring 54.4 9.7
10 SAUSA300_1058 Hla, alpha-toxin Secreted 36.0 8.7
10 SAUSA300_1150 Elongation factor Ts Cytoplasmic 32.5 5.1
10 SAUSA300_0553 Elongation factor Tu Cytoplasmic 43.1 4.5
10 SAUSA300_0235 Lactate dehydrogenase Cytoplasmic 29.4 5.1
11 SAUSA300_1988 a-Toxin Secreted 3.0 8.7
11 SAUSA300_ PSM a4 Secreted 2.2 9.7
11 SAUSA300_1067 PSM b1 Secreted 4.5 4.9
11 SAUSA300_ PSM a1 Secreted 2.3 9.7
eDNA-Binding Proteins in the Biofilm Matrix ®










































they were outside the cells, these proteins tended to remain associated with the biofilm
rather than to be washed away in the flowthrough. Since the SW analysis-identified
proteins are potential DNA-binding proteins, it suggests that these proteins may
remain associated with the biofilm through interactions with eDNA. The list of proteins
in Table S1 is dominated by highly alkaline proteins, with 41 of the proteins having pIs
of 9 or greater and another 8 having pIs of between 8 and 9, meaning that roughly 70%
of the proteins in the list would be expected to carry a net positive charge at the acidic
pH that is typical of biofilms. It is therefore reasonable to expect them to make
favorable electrostatic interactions with negatively charged eDNA. Ribosomal proteins,
many of which are known to directly interact with rRNA and/or tRNA, are highly
represented, constituting roughly 30% of the list, in excellent agreement with the ECM
proteome characterized by Graf et al. (35). Four of the ribosomal proteins and an
additional two nonribosomal cytoplasmic proteins in the list (see the Foulston et al.
column in Table S1) were previously identified as being part of the biofilm matrix by the
studies that led to the development of the electrostatic net model (33, 34), indicating
that the proteins identified by the SW technique also corroborated approximately 20%
of the cytoplasmic proteins identified in this study. Importantly, a number of proteins
known to bind DNA were identified, including Atl (bands 1, 8, and 9) (36), SarA (band
5) (37), IsaB (band 5) (38), Eap (band 1) (39), and the phenol-soluble modulins (PSMs;
band 11) (40). Interestingly, in the case of PSMs, it was further shown that the binding
of PSMs to DNA protected the DNA from digestion by DNase (40), and in the case of
Eap, it was found that this protein can condense extended DNA strands (39), raising the
possibility that Eap might also afford protection from host DNase.
Confirmation of eDNA-binding proteins via Southwestern analysis. Given that
the MS analysis indicated the presence of multiple proteins within any given SW
blotting band, follow-up studies were required to determine which protein or proteins
possessed DNA-binding activity. These studies consisted of running SW analysis on a
strain containing a deletion of the target gene or a strain in which the target gene was
expressed at an elevated level from a plasmid, and in some cases, DNA-binding activity
was confirmed using purified protein in electromobility shift assays (EMSAs). The exact
combination of techniques utilized varied for each protein to be tested.
In the case of SW blotting band 1 (Table 1), MS analysis identified three potential
DNA-binding proteins: the amidase domain of AtlA, Eap, and aerobic glycerol-3-
phosphatre dehydrogenase. Since our MS results (Table S1) indicated a high abundance
for Eap, we reasoned that at least some of the IRD700-DNA fluorescence was due to
probe binding to Eap. However, since the amidase domain of AtlA is known to bind
DNA (36), it seemed unlikely that SW analysis of an ∆eap mutant of strain LAC would
work as a means of confirming DNA-binding activity for Eap. However, given that Eap
is known to be expressed at a very high level in strain Newman (41), we reasoned that
SW analysis of a knockout mutant would work in this genetic background. SW analysis
(Fig. 2A) was conducted using membranes prepared from the Newman wild-type, ∆eap,
and complemented ∆eap strains (42), and a labeled band was obvious at the appro-
priate molecular weight (MW) in the wild-type and complemented strain lanes, while it
was absent from the ∆eap mutant lane. This observation confirmed that Eap contrib-
utes, at least in part, to SW blotting band 1 seen in Fig. 1B. Subsequently, the
DNA-binding activity of Eap has been confirmed by others using EMSAs (39).
SW analyses of knockout mutants of strain LAC were also conducted to confirm the
potential DNA-binding proteins in bands 7, 8, and 10 (Table 1). In the case of alpha-
toxin (Hla) in SW analysis band 10, the labeled band was clearly absent (Fig. 2B) in the
SW analysis of medium from a planktonic culture of a ∆hla mutant (43), which is
consistent with reports that Hla is incorporated into S. aureus biofilms and binds eDNA
(44) and the identification of Hla within both the biofilm ECM and the flowthrough (35)
but skewed toward the flowthrough. In the cases of membranes prepared from a ∆atlA
mutant grown under biofilm conditions, SW analysis bands 7 and 8, it was not possible
to confirm the protein identity, owing primarily to the weak intensity of these bands in
Kavanaugh et al. ®










































the wild-type SW analysis. The candidate eDNA-binding proteins in SW analysis bands
2, 3, 4, 5, and 9 were not amenable to validation of knockout mutants owing to the fact
that they (bands 2 through 5) contained at least one essential ribosomal protein (45) or
the candidate protein itself is essential, as was the case for LtaS (band 9). Since band
5 contains two proteins, SarA and IsaB, that are already known to bind DNA, an
alternative SW analysis approach was used to confirm the DNA-binding activity of the
third candidate identified in this band, the SaeP lipoprotein. SaeP was expressed in an
saePQRS deletion mutant (46) under the control of a xylose-inducible promoter on
plasmid pEPSA5 (45). As shown in Fig. 2C, there was a new labeled band in the
xylose-induced lane that was absent in both the sae mutant and uninduced lanes,
consistent with SaeP-binding DNA.
SW analysis-identified lipoproteins bind DNA.With the identification of SaeP and
other lipoproteins in the SW analysis screen, EMSAs were used to directly test the DNA
FIG 2 Confirmation of SW band identifications. (A) SW analysis of membranes prepared from planktonic
cultures of the Newman WT, ∆eapmutant, and complemented (Comp) ∆eapmutant strains. The position
of the Eap band is indicated by the arrow at the far right. (B) SW analysis of medium from planktonic
cultures of the LAC WT and ∆hla mutant strains. The position of the Hla band is indicated by the arrow
at the far right. (C) SW analysis of membranes prepared from biofilms of the ∆sae mutant of LAC and the
∆saemutant of LAC containing pEPSA5 expressing saeP. When expression of saeP is induced with xylose,
a new band (indicated by the arrow at the far right) corresponding to SaeP is evident in both the
Coomassie-stained and IRD700-labeled-DNA-probed gel. The numbers to the left of the gels are MW (in
kilodaltons).
eDNA-Binding Proteins in the Biofilm Matrix ®










































binding of four purified lipoproteins. These included SaeP and 0079, which has recently
been identified to be copper-binding protein CopL (47), from the SW analysis screen
(Table 1), and two lipoproteins chosen at random, open reading frame (ORF) 0100,
which belongs to the same protein family as 0419 identified in the SW analysis screen
(see “Bioinformatics analysis and perspectives of potential eDNA-binding proteins”
below), and DsbA, a known thiol-disulfide oxidoreductase protein which was included
as a control (48). Soluble, His-tagged versions of all four lipoproteins lacking the
secretion leader were cloned, overexpressed in Escherichia coli, and purified to homo-
geneity by Ni-affinity chromatography (Fig. 3A). When initial EMSAs were run using
low-percentage polyacrylamide gels, the IRD700-labeled double-stranded DNA
(dsDNA) probe failed to migrate out of the wells in lanes containing protein (data not
shown). This observation suggests that high-MW protein-DNA complexes formed as a
result of nonspecific binding to the probe. In order to resolve the high-MW complexes
and to determine whether electrostatic interactions drive nonspecific binding to the
DNA, the proteins were dialyzed into buffer systems of various pHs (pH 9.6, 8.0, and 6.5)
and agarose gels were used in place of polyacrylamide gels (Fig. 3B to D). The
subsequent EMSAs clearly indicated that all four lipoproteins bound the dsDNA probe
with affinities that were in part dependent on the overall net charges of the proteins.
At pH 9.6, all four proteins are expected to carry net negative charges, given the pIs of
9.2, 9.0, 7.7, and 9.2 for SaeP, 0079, 0100, and DsbA, respectively, and very little shifting
of the probe was observed (Fig. 3B). At pH 8.0, the predicted protein net charges
ranged from 21 to 17, and both SaeP and DsbA showed pronounced binding (Fig. 3C),
while 0100 showed some binding and 0079 did not bind at all. At pH 6.5, the proteins
were quite positively charged, with net charges ranging from 14 to 114, and each of
the four showed nearly complete probe binding (Fig. 3D). Based on the apparent
relationship between the net protein charge and affinity for DNA, all of the proteins
FIG 3 DNA-binding activity of purified lipoproteins SaeP, 0079 (CopL), 0100, and DsbA. (A) SDS-PAGE of Ni-affinity chromatography-
purified His-tagged lipoproteins that were cloned in pET28a and expressed in E. coli. The numbers to the left of the gel are MW (in
kilodaltons). (B to D) EMSAs run at pH 9.6 (B), pH 8.0 (C), and pH 6.7 (D), using ethanolamine-Capso, Tris-acetate, and bis-Tris–Aces
pKa-matched buffer systems, respectively. For each protein, a serial 2-fold dilution series (20 to 2.5 mM or 40 to 2.5 mM) was combined with
a 259-bp, IRD700-labeled DNA probe at a final concentration of 5 nM, and the mixture was incubated for 30 min at room temperature and
then electrophoresed on 1% agarose gels that had been cast with the appropriate pKa-matched buffer. Following electrophoresis, gels
were scanned using the 700-nm channel on an Odyssey CLx imager (LI-COR, Omaha, NE) and visualized using Image Studio software.
Kavanaugh et al. ®










































should have even higher affinities for DNA at the acidic pHs associated with S. aureus
biofilm formation (20).
Contribution of lipoproteins to S. aureus biofilm formation. Considering the
identification of the SaeP lipoprotein in the SW analysis screen (Fig. 2C and Table 1), the
confirmation of its DNA-binding activity by EMSA (Fig. 3), and the connection between
Sae regulation and biofilm formation (49, 50), we became interested in determining the
contribution of SaeP to S. aureus biofilm development. A markerless knockout of saeP
was constructed in the USA300 LAC strain and engineered in a way as to not impact the
expression of the saeQRS transcript. Growth curves revealed no changes in growth for
the ∆saeP mutant (Fig. S1A), and, surprisingly, microtiter assays showed no change in
biofilm formation in the ∆saeP mutant from that in the WT (Fig. S1B). If SaeP promotes
biofilm formation through interactions with eDNA in the biofilm matrix, then failure of
the ∆saeP mutation to impact biofilm formation may be due the presence of lipopro-
teins with redundant DNA-binding activity. Given this, we decided to pursue an
alternative strategy and investigate whether increasing the expression level of SaeP
could impact biofilm formation. Since the SW and EMSA analyses identified additional
lipoproteins with DNA-binding activity, we chose to examine multiple lipoproteins at
the same time.
For initial testing, the four lipoproteins with EMSA-confirmed DNA-binding activity
(SaeP, 0079 [CopL], 0100, and DsbA) and three others with various pIs (USA300 ORFs
0175 with a pI of 8.7, 1436 with a pI of 6.2, and 1478 with a pI of 6.8) were chosen from
the chromosome for comparison. Each lipoprotein was cloned into pEPSA5 to allow
xylose induction and then expressed at various levels in USA300 strain LAC. As shown
in Fig. 4A, a number of the lipoproteins had a significant impact on S. aureus biofilm
formation compared to the effect of the empty-vector control. Notably, SaeP and 0079
(CopL), as well as 0100, all dramatically enhanced the biofilm formation capacity, even
at lower xylose levels. 1478 also dramatically enhanced the biofilm formation capacity
at high xylose levels but had a more modest enhancement at lower xylose levels.
Likewise, DsbA enhanced biofilm formation only at high levels of xylose. Similarly, 0175
exhibited a very small increase in biofilm formation only at the higher xylose concen-
trations, and 1436, the protein with the lowest pI, had no impact on biofilm formation.
As a further measure of the impact of overexpressing the lipoproteins upon biofilm
formation, two of the strains overexpressing the lipoproteins SaeP and DsbA were
grown in flow cells. Consistent with the results of the microtiter plate biofilm assays,
biofilm enhancement was also observed when SaeP was expressed under flow condi-
tions (Fig. 4B), where the basal expression of SaeP expression from the pEPSA5 vector
resulted in an increase in the average biomass compared to that for the empty-vector
control (51.90 versus 22.61 mm3/mm2), and an intermediate level of biofilm formation
was observed with DsbA. The finding that multiple lipoproteins with confirmed DNA-
binding activity can dramatically enhance biofilm formation suggests that under nor-
mal growth conditions, multiple lipoproteins, including some yet to be identified or
tested, may contribute to biofilm stability by cross-linking noncovalently with eDNA in
the biofilm matrix.
Evaluating the impact of SaeP localization on biofilm enhancement. As shown
above, SaeP and other lipoproteins identified in the SW analysis screen (Table 1) bind
DNA (Fig. 3B to D) and enhance biofilm formation (Fig. 4A and B), suggesting that they
may represent an extension of the electrostatic net model of S. aureus biofilm forma-
tion. In this regard, the noncovalent, electrostatic interactions between lipoproteins
and the high-MW eDNA might function as direct cross-links between the bacterial
surface and the biofilm matrix, thus promoting bacterial aggregation as well as biofilm
formation and stabilization. If the lipoproteins function through this mechanism, then
the enhancement should be dependent upon proper anchoring to the membrane, the
accessibility of the DNA-binding domain, and the presence of eDNA.
We first investigated the impact of SaeP localization on enhancement of biofilm
formation. Previous work showed that SaeP can be detected in the spent medium
eDNA-Binding Proteins in the Biofilm Matrix ®










































of an lgt mutant (51), supporting its assignment as a lipoprotein. To verify that SaeP
is exposed to the extracellular environment, we used the substituted cysteine
accessibility method (SCAM) (52), which relies on a thiol-reactive reagent, N-(3-
maleimidylpropionyl)biocytin (MPB), to attach biotin to cysteine side chains. Since MPB
does not penetrate S. aureus, only cysteines on the outside of the cell are labeled,
unless the bacteria are pretreated with lysostaphin, in which case intracellular cysteines
also are labeled. Application of SCAM requires that the protein being analyzed contain
only one reactive cysteine; hence, the method often requires that cysteine residues be
added or removed from the protein through site-directed mutagenesis. However, given
that SaeP contains only two cysteine residues, C21 and C133, C133 should be the only
reactive cysteine in the mature lipoprotein, since C21 is the site of lipidation. Therefore,
it was possible to conduct the SCAM analysis without modifying the native SaeP amino
acid sequence. When S. aureus cells expressing SaeP (with a C-terminal T7 tag) were
reacted with MPB, biotin-labeled C133 was detected in both the presence and the
absence of lysostaphin pretreatment, indicating that C133 is exposed to the extracel-
lular environment and that the domain is accessible (Fig. 4C). Interestingly, pretreat-
ment with lysostaphin revealed three discrete bands labeled with MPB (streptavidin
[Strep]-horseradish peroxidase [HRP] gel) migrating very close together, suggesting
that the pre-SaeP, pro-SaeP, and mature SaeP forms were labeled, while the absence of
FIG 4 Impact of lipoprotein expression and localization on S. aureus biofilm development. (A) LAC strains were constructed with the
pEPSA5 empty vector (EV) or various lipoproteins. Biofilms were grown in 48-well plates in TSB plus 0.4% glucose and xylose at a range
of concentrations (0 to 0.6%) to induce protein expression. Error bars are the standard deviation for 12 wells (three experiments with
four wells per lipoprotein). Statistics for two-way analysis of variance are P values. **, P # 0.005; ***, P # 0.0005; ****, P # 0.00005. (B)
Confocal microscope images of flow cell biofilms for the strain with the empty vector (left), SaeP-expressing strains (center), and
DsbA-expressing strains (right). Biofilms were grown for 2.5 days in 2% TSB supplemented with 0.2% glucose, 1 mg/ml of chloram-
phenicol, and 0.1% xylose. (C) SCAM analysis of native SaeP in strain LAC shows that cysteine residue C133 is modified without
lysostaphin pretreatment, indicating that SaeP is located on the cell surface. Protein expression was evaluated by T7 immunoblotting,
while cysteine labeling was analyzed using Strep-HRP. (D) Western blot analyses performed with whole-cell lysates and bacterial
supernatants of LAC expressing WT SaeP-T7 or the C21A mutant of SaeP-T7 show that the WT protein is associated with cells, whereas
the C21A mutant is found in the supernatant, confirming that the C21A mutant is no longer a lipoprotein. (E) Biofilm assays, performed
as described in the legend to panel A, of WT and C21A mutation-expressing strains (compared to strains expressing DsbA as a control)
show that the mutant no longer supports enhanced biofilm accumulation. Error bars are the standard deviation for three replicate
wells. Statistics for two-way analysis of variance are P values. ****, P # 0.00005.
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lysostaphin pretreatment showed MPB labeling of only the fastest-migrating species,
corresponding to the mature form of SaeP (53). MPB labeling of SaeP did not occur
when C133 was mutated to an alanine, confirming that C133 is the reactive cysteine in
SaeP.
In order to test whether anchoring of SaeP to the cellular membrane is necessary for
biofilm enhancement, we generated a construct that eliminated the lipidation site
(C21A). The C21A mutant was detected in culture supernatants, and very little was
found in whole cells (Fig. 4D), suggesting that the C21A mutant is secreted and no
longer a lipoprotein. Conversely, WT SaeP was detected predominantly in whole cells,
as would be expected for a lipoprotein. Importantly, when the microtiter plate biofilm
assay was repeated with various levels of WT SaeP or C21A mutant expression (com-
pared to the level of expression of the DsbA control), WT SaeP caused a dramatic
enhancement of biofilm formation, as expected, while the C21A mutant showed no
increase in biofilm formation (Fig. 4E), indicating that membrane anchoring and surface
localization are required for enhanced biofilm formation. As a final localization exper-
iment, SaeP was purified by affinity chromatography and added directly to LAC biofilms
at the time of culture inoculation. Over a wide range of SaeP concentrations, no
changes in biofilm formation were evident (Fig. S2). Taken together, these results show
that SaeP must be tethered to the S. aureusmembrane surface on the extracellular face
to mediate an increase in biofilm formation.
SaeP enhances biofilm capacity in an eDNA-dependent manner. Considering the
results presented above, we predicted that the SaeP-based biofilm enhancement would
be mediated through interactions with eDNA. We tested this prediction using an atlA
mutant, which has reduced autolysis and eDNA levels (54). Expression of saeP in the
atlA mutant failed to enhance biofilm formation and resulted in a biofilm profile similar
to that of the empty-vector control (Fig. 5A), suggesting a dependence on eDNA. To
determine whether eDNA levels were altered by the presence of SaeP, biofilm matrix-
associated eDNA was isolated from WT LAC cultures expressing SaeP. Substantially
more high-MW eDNA than was observed for the empty-vector control was detected in
the matrix at increased levels of SaeP expression (Fig. 5B); the empty-vector control had
only a small amount of low-MW (,100-bp) DNA (Fig. 5B).
Since the presence of SaeP results in biofilms with higher eDNA levels, we predicted
that the SaeP-dependent enhancement of biofilm formation should be sensitive to the
presence of a nuclease. To test this prediction, a dilution series of purified S. aureus
nuclease (Nuc) was added at the time of inoculation to cultures in which SaeP was
expressed at high levels by xylose induction. At added Nuc concentrations of 6.5 U/ml
and above, there was a significant, dose-dependent decrease in biofilm formation
(Fig. 5C), further demonstrating the importance of eDNA to the SaeP-dependent biofilm
enhancement.
Contribution of lipoproteins to S. aureus biofilm structure. Our collective results
indicated that different membrane-attached lipoproteins likely contribute to the sta-
bility of S. aureus biofilms, suggesting that deletion of any one lipoprotein would not
have a measurable impact on the amount of biofilm biomass. This was supported by
our findings with the saeP mutant (Fig. S1B). Nevertheless, we reasoned that if a
sufficient number of lipoproteins were inactivated, then the ability of S. aureus to form
biofilms or the structure of the biofilm itself could be impacted. In this regard, the
lipoproteins belonging to the conserved staphylococcal antigens (Csa) family presented
a unique opportunity to test this hypothesis. As described in “Bioinformatics analysis
and perspectives of potential eDNA-binding proteins” below, the Csa family in S. aureus
USA300 strains consists of 14 highly homologous lipoproteins that are distributed
within four distinct loci on the chromosome, and some of these lipoproteins, such as
SAUSA300_0419, were identified in the SW analysis screen (Table 1). We tested the
contribution of Csa lipoproteins to the biofilm structure by making serial deletions on
the USA300 chromosome: ∆locus I and ∆lpl (also called locus III) single mutants, a ∆locus
eDNA-Binding Proteins in the Biofilm Matrix ®










































I ∆lpl double mutant, and a ∆locus I ∆lpl ∆locus IV triple mutant. The USA300 chromo-
some does not contain locus II.
Since it has been shown that sub-MICs of b-lactam antibiotics cause S. aureus to
form thicker eDNA-dependent biofilms (55, 56), we used this protocol to initially assess
biofilm formation by the ∆csa mutants. However, none of the ∆csa locus mutants
showed a reduced biofilm formation capacity in this assay (Fig. 6A). Since S. aureus
biofilms grown in the presence of sub-MICs were also found to be less porous than
biofilms grown without antibiotic (55), we decided to test whether biofilm porosity was
impacted in the ∆csa mutants. For this approach, we measured the movement of
various-molecular-weight fluorescein isothiocyanate (FITC)-dextrans and proteins
through biofilms that were grown on ultrafiltration membrane filters (Fig. 6A). Previous
studies demonstrated that convection through biofilms grown on ultrafiltration mem-
branes was impacted by the polysaccharides and/or eDNA in the biofilm (55, 57).
Biofilms were grown on 96-well filter plates containing polyvinylidene difluoride (PVDF)
membranes with 0.45-mm pores. After 24 h of static incubation at 37°C, culture super-
natants were removed from the plates by aspiration and replaced with buffer contain-
ing FITC-dextran of a particular molecular weight (either 4,000 [4K], 10K, 70K, or 150K
at 1 mg/ml) or a mixture of proteins of different molecular weights (bovine serum
albumin [BSA] at 66 kDa, Saccharomyces cerevisiae yeast alcohol dehydrogenase [ADH]
FIG 5 SaeP-induced biofilm enhancement is dependent on eDNA. (A) SaeP was expressed from pEPSA5 in an atlA mutant
under biofilm-forming conditions using a range of xylose concentrations (0 to 0.6%) to induce protein expression. Error
bars are the standard deviation for three replicate wells. (B) SaeP expression results in the accumulation of eDNA in the
biofilm matrix. Static biofilms expressing either SaeP or DsbA were grown in TSB supplemented with 0.4% glucose and
xylose at the indicated concentrations. eDNA isolated from the biofilm matrix was run on agarose gels. The numbers to
the left of the gel are MW (in kilodaltons). (C) Biofilm enhancement of LAC expressing WT SaeP at 0.6% xylose is reduced
when purified Nuc is added at time zero. Statistics for two-way analysis of variance are P values. *, P # 0.05; **, P # 0.005;
***, P # 0.0005; ****, P # 0.00005.
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at 150 kDa, and b-amylase at 200 kDa). Filter plates were then subjected to a brief,
low-speed centrifugation, and the concentrations of the FITC-dextran and proteins in
the flowthrough were determined by fluorescence or densitometry of the SDS-PAGE
gels, respectively.
As shown in Fig. 6B, serial deletion of the Csa lipoproteins resulted in an increased
flowthrough of FITC-dextrans. Of note, as progressively more Csa loci were deleted,
there was a trend toward increased passage for each FITC-dextran. However, the point
at which a statistically significant increase in FITC-dextran flowthrough was observed
was dependent on the number of Csa loci deleted. For the smallest 4K FITC-dextran,
there was no significant increase in flowthrough until all three USA300 Csa loci were
FIG 6 Lipoprotein mutants show increased biofilm porosity. (A) Biofilm biomass for Csa knockout mutants measured by
crystal violet staining and expressed as a fraction of the WT biomass. Values are averages from either two or three
experiments (.45 wells per strain tested). (B) Concentrations of different-molecular-weight FITC-dextrans in the flow-
through of filter-grown biofilms (12 wells per experiment). Concentrations are expressed as the fraction of the FITC-dextran
concentration in the flowthrough of wells containing sterile medium (i.e., no-biofilm control wells). Statistics for two-way
analysis of variance are P values. *, P # 0.05; **, P # 0.005; ***, P # 0.0005. (C) Protein band intensities from SDS-PAGE of
the filter-grown biofilm flowthrough, expressed as the fraction of the intensity for the corresponding band in the protein
loading solution. Values are the averages from two experiments with .14 wells per strain tested (except that 3 wells were
used for the triple mutant). Statistics for two-way analysis of variance are P values. *, P # 0.05; **, P # 0.005. (D) Biofilm
biomass for the WT and CopL mutant measured by crystal violet staining and expressed as a fraction of the WT biomass.
Values are averages from two experiments with .40 wells per strain tested. Statistics for one-way analysis of variance are
P values. *, P # 0.05; **, P # 0.005. (E) Concentrations of different-molecular-weight FITC-dextrans in the flowthrough of
filter-grown biofilms. Concentrations are expressed as the fraction of the FITC-dextran concentration in the flowthrough
of wells containing sterile medium. Values are the averages from two experiments with 12 wells per strain per experiment.
Statistics for two-way analysis of variance are P values. **, P # 0.005.
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deleted. For the 10K FITC-dextran, there was a significant increase in flowthrough in
both the triple and double deletion mutants, and for the 70K and 150K FITC-dextrans,
there were significant increases in flowthrough for all the deletion mutants. This trend
is consistent with the loss of interactions between the Csa lipoproteins on the bacterial
cell surface and eDNA leading to larger pores and channels within the biofilm and,
consequently, easier passage of the higher-molecular-weight FITC-dextrans through
the biofilm. Importantly, the flowthrough of proteins (Fig. 6C) showed similar relation-
ships between the number of loci deleted, the solute molecular weight, and flow-
through, reinforcing the interpretation of increased FITC-dextran flowthrough.
In order to test the generality of the inferred relationship between biofilm porosity
and the number of interactions between the lipoproteins on the cell surface and the
eDNA in the matrix, we repeated the analysis of FITC-dextran flowthrough using
biofilms of a CopL (SAUSA300_0079) deletion mutant. Importantly, CopL was identified
in the SW analysis screen (Table 1, band 4); purified CopL bound DNA, as indicated by
EMSA analysis (Fig. 3); and overexpression of CopL resulted in increased biofilm
biomass (Fig. 4A). Unlike the ∆csa mutants, the copL mutant did show a small but
statistically significant decrease in biofilm biomass in both the absence and the
presence of sub-MICs of antibiotic (Fig. 6D). When the FITC-dextran flowthrough was
quantified (Fig. 6E), all the FITC-dextrans showed a trend toward increased rates of
flowthrough in the copL mutant biofilms, which was consistent with the interpretation
of the ∆csa mutant flowthrough measurements.
Contribution of proteins Eap and IsaB identified by SW analysis to eDNA
binding. Besides the lipoprotein candidates, the SW blotting approach identified a
number of other eDNA-binding proteins of interest (Table 1). We examined two of the
better-characterized proteins identified in more detail, starting with the extracellular
adherence protein (Eap) and immunodominant surface protein B (IsaB). Both Eap and
IsaB are characterized, secreted proteins, and both are known to bind DNA (38, 39).
Coupled with our SW analysis results (Fig. 2A), we were confident about their localiza-
tion and eDNA-binding properties. To test the hypothesis that these proteins contrib-
ute to the structure of the S. aureus biofilm matrix, we first constructed knockouts of
eap and isaB in the USA300 LAC background, and like the ∆saeP mutant and the ∆csa
mutants, these mutants had no significant impact on biofilm formation in microtiter
assays (Fig. S4). We decided to test the effect of these genes on biofilm formation in
another strain background, HG001, where high levels of secreted IsaB were reported
(58). In HG001, a 2-fold decrease in biofilm formation was observed in the isaB single
mutant, as well as in a double mutant in which the eap gene was also disrupted
(Fig. S4), but still no effect was observed for the eap mutant. We reasoned that Eap and
IsaB might redundantly bind surface eDNA in the matrix, and their respective contri-
butions may relate more to the biofilm structure than to a net contribution to biomass.
In order for Eap and IsaB functions to be assessed in surface eDNA binding, an assay
was developed using approaches pioneered by Kaplan and colleagues (56). We found
that proteinase K treatment was critical to the release of the S. aureus eDNA from the
surface proteins (Fig. 7A). In our analysis, we focused on high-MW eDNA, since previous
work has shown that .11 kb is necessary to function as a biofilm matrix polymer (59).
Interestingly, observable amounts of high-MW eDNA could not be recovered from the
LAC biofilm matrix, whereas significant amounts of high-molecular-weight DNA were
extracted from the HG001 matrix (Fig. 7A), suggesting either that the LAC biofilm does
not contain high-molecular-weight DNA or that the DNA is degraded during the
extraction process. When the level of Nuc activity was compared between the two
strains, LAC produced a high level, typical of USA300 strains (49), while HG001 com-
paratively produced very little (Fig. 7B), similar to the level of strain SH1000 (50). These
observations suggest that Nuc degrades the available high-MW eDNA, and in accor-
dance with this hypothesis, the LAC nuc mutant does accumulate high-MW eDNA
(Fig. 7C).
With the method described above, we assessed the role of IsaB and Eap in binding
surface eDNA using single and double mutant strains. When eDNA was isolated
Kavanaugh et al. ®










































(Fig. 7D), a dramatic reduction in eDNA levels associated with the biofilm matrix was
observed when both eap and isaB were deleted in HG001 or in the LAC nuc mutant. A
partial loss of eDNA was also observed in the HG001 single mutants. These findings
suggest that within the biofilm, Eap and IsaB collectively contribute to the retention of
eDNA at the S. aureus surface. Although in the microtiter plate assays the biofilms the
LAC strain showed minimal phenotypes (Fig. S4), we reassessed this under flow
conditions, where we observed a significant decrease in both overall biomass and the
maximum thickness of the LAC nuc eap isaBmutant compared to the nuc single mutant
(Fig. 7E). These results suggest that the loss of eDNA-binding proteins contributes to
reduced S. aureus biofilm formation, at least in environments with sheer stress.
Due to the multitude of eDNA-binding proteins identified by the SW blotting
method, we moved constructs expressing SaeP and DsbA into the LAC nuc isaB eap
mutant. A significant increase in matrix-associated eDNA was observed when either of
these proteins was expressed at high levels (Fig. 7F), with much greater eDNA retention
being observed when SaeP was expressed. The trans-complementation approach
suggests that secreted eDNA-binding proteins can function in a redundant capacity to
retain surface eDNA in the biofilm matrix. Since these strains retain greatly increased
levels of eDNA, they would be expected to form biofilms with a greatly reduced
porosity. Studies are under way to assess whether this is in fact the case.
SaeP levels impact nuclease expression. Based on studies conducted thus far, it
is clear that SaeP is a membrane-anchored lipoprotein that faces the extracellular
FIG 7 Eap and IsaB impact the surface eDNA and biofilm structure. (A) Release of surface eDNA from HG001 and LAC biofilms with and without
proteinase K. (B) Nuc activity, measured by FRET assay, in HG001 and LAC WT and nuc mutant strains. (C) Release of surface eDNA from LAC WT
and nuc mutant biofilms. (D) Release of surface eDNA from isaB, eap, and double mutants in HG001 and LAC backgrounds. (E) Confocal
microscopy images of the LAC nuc mutant versus the nuc isaB eap triple mutant. (F) Release of surface eDNA from the LAC nuc isaB eap triple
mutant expressing DsbA or SaeP.
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environment and binds eDNA, thereby enhancing biofilm formation. However, given
that SaeP is an auxiliary protein of the SaeRS two-component system that works with
SaeQ to modulate the activity of the SaeS sensor kinase (51), it is possible that high
levels of SaeP expression could promote biofilm formation by reducing the activity of
SaeS and thereby indirectly reducing the levels of secreted Nuc (49, 50). To compare
and evaluate these different SaeP functions, Nuc levels were measured during overex-
pression of SaeP and compared to biofilm growth. As expected, SaeP enhanced the
biofilm formation capacity beyond that for the empty vector (Fig. 8A) at xylose levels
of 0.2% and above. The same SaeP expression levels corresponded to a decrease in Nuc
activity (Fig. 8B), approaching almost nondetectable levels at 0.4 and 0.6% xylose. This
observation suggests that SaeP-dependent repression of Nuc activity could impact the
ability of S. aureus to form a biofilm; however, the observed levels of Nuc activity within
the biofilm (Fig. 8B) were nearly 50-fold lower than the amount of exogenously
supplied Nuc that was required to impact biofilm formation (Fig. 5C), suggesting that
the regulatory activity of SaeP had at best only a minimal impact in the various static
biofilm assays described above. Consistent with this interpretation are the findings that
overexpression of SaeP in either a nuc mutant (50) or a mutant with a complete
deletion of the saePQRS operon (46) still resulted in increased biofilm formation
(Fig. S3A) and allowed for the extraction of increased levels of high-molecular-weight
DNA (Fig. S3B). Collectively, these observations suggest that the enhanced biofilm
formation associated with the overexpression of membrane-anchored lipoproteins
described above is primarily due to interactions between the lipoproteins and eDNA
within the matrix. The observation that the overexpression of SaeP can reduce Nuc
activity (Fig. 8B) raises the possibility that at normal levels of expression SaeP can
modulate biofilm formation by impacting Nuc expression when Nuc expression is not
suppressed by glucose supplementation of the growth medium (49, 50).
To examine the impact of SaeP on nuc expression, we utilized a BioFlux microfluidics
device, which allows for a more comprehensive assessment of biofilm development.
Importantly, the growth medium used for this study, 50% tryptic soy broth (TSB), did
not contain supplemental glucose, as was the case for the medium used in the various
microtiter plate assays described above. Consistent with the above-described experi-
ments indicating a negative effect of SaeP on nuc regulation (Fig. 8B), growth of the
∆saeP mutant containing the nuc reporter plasmid revealed that the stochastic expres-
sion observed in the WT strain was nearly eliminated, with the majority of the cells
demonstrating nuc expression (Fig. 8C and D). In contrast, the temporal control of nuc
expression appeared to be similar to that of the WT strain, with induction occurring at
about 2.5 h after initiation of the experiment. Given these findings, it would appear to
be highly plausible that the normal expression levels of SaeP may play a significant role
in the regulation of biofilm development. Ongoing studies are aimed at elucidating the
function of the SaeRS system and of SaeP in particular in modulating the S. aureus
biofilm lifestyle.
Bioinformatics analysis and perspectives on potential eDNA-binding proteins.
Additional bioinformatics analysis was performed on the many other candidates iden-
tified by SW analysis and listed in Table 1 (and Table S1). Literature searches looking for
any evidence of DNA-binding activity were conducted, and in addition, the amino acid
sequences of hypothetical proteins were submitted for structural prediction on the
Phyre2 server (60). As was to be expected, many of the ribosomal proteins identified by
the SW analysis are known to interact with nucleic acids, either rRNA, tRNA, or mRNA.
Beyond these candidates, bioinformatics structural analysis of two lipoproteins identi-
fied in SW analysis band 2, encoded by ORFs 0419 and 1790, suggests that they may
bind eDNA with a high affinity.
The 0419 ORF encodes one of nine lipoproteins, referred to as Lpl1 through Lpl9
(also called Csa3A through Csa3I), that are encoded by ORFs 0410 through 0419 on the
USA300 chromosome. They are located in the lipoprotein-like (lpl) cluster found within
the type I vSaa island in S. aureus strains belonging to clonal complex 5 (CC5) and CC8
(61). The nine Lpl proteins share significant sequence homology, with an average
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percent identity of 61% and a range of identities of 46% to 83%. As a group, the mature
Lpl proteins are very basic, with an average theoretical pI of 8.2, suggesting that they
should make favorable electrostatic interactions with negatively charged eDNA at
neutral pH or under the low-pH conditions found in S. aureus biofilms. While no
FIG 8 SaeP levels impact Nuc expression. (A) SaeP was overexpressed in LAC under biofilm-forming conditions, and the
adherent biomass was quantified using crystal violet. Error bars are the standard deviation for three replicate wells. (B)
Biofilm supernatants were filter sterilized and tested for nuclease activity using a Nuc FRET assay. Error bars are the
standard deviation for four replicate assays. P values were determined by Student’s t test. ***, P # 0.0005. (C) BioFlux
images of the WT and saeP mutant with the Pnuc-GFP reporter. (D) Quantification of the cell coverage and fluorescent
coverage of the images in panel C.
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structures have been determined for the proteins encoded in the lpl cluster, sequence
homology (Fig. S5A) indicates that they belong to a family of proteins, the conserved
staphylococcal antigens (Csa) family (61–63), for which X-ray crystal structures exist
(Fig. S5B and C). Importantly, the Csa family includes the protein encoded by ORF 0100,
which was shown to bind DNA with a high affinity by EMSA analysis (Fig. 3), which
suggests that all of the Csa proteins may bind DNA.
Examination of the available Csa family crystal structures suggests an explanation
for the observed high DNA-binding activity of lipoprotein 0100. The RCSB Protein Data
Bank (PDB) (64) contains X-ray crystal structures for 0100-encoded Csa1A (PDB acces-
sion number 4BIG [63]), Csa1B (PDB accession number 4BIH, [63]), and Csa4A (PDB
accession number 4EGD). Affinity pulldown and surface plasmon resonance experi-
ments utilizing purified proteins suggest that Csa paralogs can physically interact with
each other (63), and the asymmetric unit in Csa4A (PDB accession number 4EGD)
(Fig. S5D) suggests that they may interact to form split b-barrel structures in which
b-strands 3, 4, and 5 along with a4 form the dimer interface. Importantly, with an
interior diameter in the range of 20 to 25 Å, the barrel is sufficiently large to accom-
modate a dsDNA helix. Given the high pIs of the Csa proteins noted above and the fact
that proteins that utilize b-sheets to bind DNA have positive electrostatic potentials on
their surfaces (65), electrostatic surface potentials were calculated for each of the Csa
proteins. Atomic models were generated using the Phyre2 server and the structure with
PDB accession number 4EGD as a template, and electrostatic potentials were calculated
using the PDB2PQR server (66) and PyMOL (The PyMOL molecular graphics system,
version 2.1; Schrödinger, LLC). When electrostatic surface potentials were calculated
over a range of pHs for two of the Lpls, Lpl1 and Lpl7, the concave surface of the
b-sheet was highly positive (Fig. S5E) when the solvent-accessible surface potential was
displayed in the same orientation (Fig. S5B). When the electrostatic potentials for each
of the Csa proteins were calculated at pH 5 and displayed in the same orientation
(Fig. S5F), it is clear that a number of them, including 0100, also had a very positive
charge distribution on the concave face of their b-sheets. If the Csa proteins do in fact
form split b-barrels, then at the low pH values where S. aureus biofilms form, the interior
surface of the barrel would be highly positive, as has been observed for other proteins
that use b-sheets to bind DNA (65).
Structural analysis suggests that the lipoprotein encoded by SAUSA300_1790 may
also promote S. aureus biofilm formation by moonlighting as an eDNA-binding protein.
ORF 1790, which encodes the bacterial extracellular foldase PrsA, was identified by SW
analysis at a similar high abundance in both membrane band 2 and medium band 10
(Table S1), which is consistent the findings obtained by MS recently reported by Graf et
al. (35). PrsA is a highly conserved, essential lipoprotein that contains two subdomains:
an NC domain (consisting of the N- and C-terminal portions of the protein) and an
intervening parvulin-like domain responsible for the peptide-propyl cis-trans isomerase
(PPIase) activity of the protein (67). Relative to PrsA in Bacillus subtilis (Fig. 9A) and other
Gram-positive bacteria (67), S. aureus PrsA contains a 15-amino-acid insertion in the
parvulin domain, which is indicated by the magenta bar in the alignment of the S.
aureus and B. subtilis PrsAs shown in Fig. 9A generated with the Clustal Omega
program. The parvulin domains of the bacterial PrsAs also share significant sequence
homology with human parvulin, as illustrated by the alignment of S. aureus PrsA with
human hPar14 (Fig. 9B). Interestingly, S. aureus PrsA contains the same insertion relative
to human parvulin as it does relative to other bacterial PrsAs, suggesting that acqui-
sition of the insertion may be a recent evolutionary event. The dimeric X-ray crystal
structure of B. subtilis PrsA (PDB accession number 4WO7 [67]) shows a large, bowl-
shaped crevice that is roughly 25 Å wide and 40 Å deep, with the NC domains (teal and
yellow in Fig. 9C) being the closest to the cell membrane and the parvulin domains
(dark blue and orange/magenta in Fig. 9C) being at the top of the bowl. The structure
of the complete S. aureus PrsA has not been determined, but a nuclear magnetic
resonance (NMR) structure of the parvulin domain (PDB accession number 2JZV) has
been published previously (68). In Fig. 9C, the S. aureus NMR structure is superimposed
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FIG 9 PrsA bioinformatics. (A) Alignment of S. aureus PrsA (Sa_PrsA) with Bacillus subtilis PrsA (Bs_PrsA) determined with the Clustal Omega program (89) and
prepared using the ESPript2.2 program (90), in which identical residues are highlighted in red and similar residues are shown in red text. Secondary structure
elements from the B. subtilis X-ray crystal structure (PDB accession number 4WO7) are indicated above the sequence, and the color bars below the sequences
correspond to the subunit colors in panel C, with the NC and parvulin domains of subunit 1 being indicated by teal and dark blue, respectively, and the NC
and parvulin domains of subunit 2 being indicated by yellow and orange, respectively. The magenta bar under parvulin domain 1 indicates the amino acid
insertion found in S. aureus PrsA. (B) Alignment of S. aureus PrsA with human parvulin protein hPar14 determined with the Clustal Omega program. The amino
acid insertion in S. aureus PrsA is indicated by the magenta bar, and the green bars indicate the hPar14 residues whose NMR chemical shifts were sensitive to
the addition of DNA. (C) Image, generated with PyMOL (The PyMOL molecular graphics system, version 2.1; Schrödinger, LLC), showing the molecular surface
of the B. subtilis PrsA crystal structure (PDB accession number 4WO7), with NC domain 1 shown in teal, parvulin domain 1 shown in dark blue, NC domain 2
shown in yellow, and parvulin domain 2 shown in orange. The solution NMR structure of the S. aureus parvulin domain (PDB accession number 2JZV) is
superimposed on the parvulin domain 2 of B. subtilis, and the extra molecular surface from the amino acid substitution in S. aureus PrsA is shown in magenta.
In addition, the molecular surfaces associated with the S. aureus parvulin domain residues corresponding to the human parvulin residues with DNA-sensitive
chemical shifts are shown in green. (D) Stereo image depicting the alignment of S. aureus (PDB accession number 2JZV; yellow) and human (PDB accession
number 1FJD; teal) parvulin NMR structures, with the amino acid insertion in S. aureus, including the lysine side chains, shown in magenta and the positions
of human residues whose chemical shifts are impacted by DNA shown in green.
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on B. subtilis parvulin domain 2, so that the additional solvent-accessible surface
associated with the insertion is shown in magenta on the edge of the bowl, and in
Fig. 9D, the S. aureus NMR structure (yellow) is superimposed on the NMR structure
(PDB accession number 1FJD [69]) of hPar14 (blue), with the amino acid insertion being
shown in magenta. Significantly, hPar14 has been shown to bind short DNA duplexes
with dissociation constants (Kds) of ;200 nM (70), with the highest affinities (,190 nM)
being observed for DNA duplexes containing tracts of 5 to 6 contiguous A residues,
which would be common in eDNA derived from low-GC-content S. aureus genomic
DNA. By titrating DNA into the hPar14 solution, Surmacz et al. (70) were able to identify
residues (indicated by green bars in Fig. 9B) whose chemical shifts were sensitive to the
addition of DNA. When surfaces associated with the corresponding residues in the
parvulin domain of S. aureus PrsA are colored green (Fig. 9C and D), it can be seen that
they are located along the inner face of the crevice/bowl of dimeric bacterial PrsA,
suggesting that DNA may bind within the bowl. Interestingly, the insertion that is
unique to S. aureus contains several lysine side chains (shown in magenta in Fig. 9D)
that would project into the bowl, where they could potentially enhance the ability of
S. aureus PrsA to bind DNA relative to other bacterial PsrAs.
DISCUSSION
In this work, we developed and verified a method for identifying eDNA-binding
proteins involved in S. aureus biofilm development. The approach is based on SW
blotting methods pioneered to investigate DNA-protein interactions (71). Using the
new method, we identified a number of lipoproteins and cell surface-associated
proteins that bind DNA, and selected candidates were confirmed and subsequently
shown to impact biofilm structure. As anticipated, proteins with known DNA-binding
activity were identified, such as the major autolysin Atl, IsaB, Eap, and PSMs, but more
interestingly, many uncharacterized proteins were uncovered in the screen. Of these
candidates, a number of lipoproteins were detected, and some were investigated
further and shown to bind eDNA, positively impact S. aureus biofilm development, and
influence biofilm porosity.
The findings reported here complement and extend the electrostatic net model of
biofilm development in S. aureus (33, 34). According to this model, cytoplasmic proteins
that are released into the extracellular environment through autolysis promote biofilm
formation by moonlighting as eDNA-binding proteins. At the acidic pHs associated with
biofilm formation, the positively charged proteins can form favorable, attractive elec-
trostatic interactions with both eDNA and the negatively charged teichoic acids found
on the cell surface. When the eDNA within the biofilm matrix is of high MW, multiple
bacterial cells can associate with any given DNA molecule, promoting cellular aggre-
gation. Since the positively charged proteins also insert between individual DNA
molecules, the proteins function as noncovalent links between DNA molecules that
would otherwise repulse one another. Therefore, the moonlighting proteins effectively
create a network of favorable, attractive electrostatic interactions resembling a net,
which promotes cellular aggregation and biofilm development.
Virtually all of the proteins identified by our SW blotting screen (see Table S1 in the
supplemental material) were found in the biofilm ECM and/or the biofilm flowthrough
in a very recent, comprehensive MS analysis of S. aureus biofilms (35), and roughly 20%
of the proteins that we identified were also found in the studies on the electrostatic
model (33, 34). By far, the largest differences between the list of proteins that we
identified and the proteins identified by these other studies are proteins that we failed
to identify as contributing to the biofilm matrix. However, since many of the proteins
found to be enriched in biofilms may not have DNA-binding activity, they would have
been missed by our approach since we purposely implemented the SW blotting screen
prior to MS analysis in order focus on potential eDNA-binding proteins. More significant
are the proteins that we identified but that were not identified or that were found at
only a low abundance in the other studies. Since we included cell membranes in our
study, the SW blotting method allowed for the identification of novel eDNA-binding
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lipoproteins that are covalently attached to the cell membrane. The others studies
relied on salt and increases in pH to release proteins associated with the cell surface
through noncovalent interactions, which means that they would be able to find only
the lipoproteins that were shed from the cell membrane. At the experimental level, this
makes our SW blotting approach complementary to the other studies, but more
importantly, it allowed us to uncover the potential roles that these lipoproteins may
play in modulating biofilm stability and porosity.
By applying the SW blotting approach to S. aureus membranes, we have extended
the electrostatic net model of biofilm development to include membrane-bound
lipoproteins that form favorable electrostatic interactions with eDNA and thereby
contribute to stabilize the biofilm and modulate biofilm porosity. It seems likely that
their contribution to the network has been overlooked due to the methods used, as
noted above. Using the SW blotting approach, we identified numerous lipoproteins as
potential DNA-binding proteins, and for several of them, we confirmed their DNA-
binding activity. EMSA analysis also indicated that the lipoproteins formed very-
high-MW complexes that were consistent with nonspecific DNA binding, an important
property for proteins that are going to contribute to the electrostatic net by binding
eDNA. Running EMSAs at different pHs demonstrated that the lipoprotein DNA-binding
activity was driven largely through attractive electrostatic interactions. We further
demonstrated that at high levels these lipoproteins were able to enhance biofilm
formation. Using SaeP as a test candidate, the enhancement in biofilm capacity was
dependent on the presence of eDNA, suggesting that the lipoproteins increase the
biofilm formation capacity by making favorable interactions with the eDNA found in
the matrix and thereby strengthening the electrostatic net. By quantifying the ability of
various-sized FITC-dextrans and proteins to diffuse through biofilms, we provide evi-
dence that these interactions can modulate biofilm porosity. The secreted eDNA-
binding proteins identified by the SW blotting screen, for example, Eap and IsaB, likely
promote biofilm formation and modulate porosity through the interactions that they
make with eDNA in the matrix. All these findings are consistent with the function of the
moonlighting proteins that stabilize the biofilm, but our observation that SaeP must be
attached to the cell surface provides a new layer to the model. Our observations
suggest that lipoproteins may function as anchor points that secure the electrostatic
net to the cell surface and that these anchor points are important for promoting biofilm
formation and modulating biofilm porosity. The fact that we were able to identify
multiple lipoproteins with DNA-binding and biofilm-promoting activity implies a sig-
nificant level of functional redundancy. Since the bioinformatics analysis suggests that
there are likely additional lipoproteins with DNA-binding activity, this redundancy may
be even more extensive than that indicated by the results of the SW blotting experi-
ments.
Structural analysis of the candidates identified by the SW blotting screen suggests
that additional lipoproteins that were not found during the SW blotting screen may
also have DNA-binding activity capable of promoting S. aureus biofilm formation. As
noted above, lipoproteins in the Csa family share a structure due to significant
sequence homology. Given that Csa lipoprotein 0100 was shown to bind DNA in the
EMSA analysis and result in an eDNA-dependent enhancement in biofilm formation
when overexpressed (Fig. 3 and 4), it is likely that many of the Csa proteins, including
the lpl proteins, possess similar DNA-binding activity that could enhance biofilm
formation. In this regard, it is interesting to note that it was recently found that
lipoproteins having an aspartate at position 12 of the lipobox are more tightly bound
to the cell surface (72) and that five of seven lipoproteins with Asp12 in S. aureus (out
of a total of 67 lipoproteins in S. aureus) are part of the lpl cluster (see the lipobox
sequences in Fig. S5A), suggesting that these proteins could serve as important
eDNA-bound anchors. Since analysis of the hypothetical Csa structures suggests that
they bind DNA using the positively charged, concave surface of a b-sheet, it is possible
that any lipoprotein that presents a positively charged, concave b-sheet on the outside
of the cell may form favorable interactions with eDNA. Our findings for lipoprotein 0079
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support this notion, as we demonstrated that this protein binds DNA (Fig. 3) and that
it results in enhanced biofilm formation when overexpressed (Fig. 4A). Analysis with
the Phyre2 server found that 0079 (CopL) has 63% sequence identity (Fig. S6A) to the
C-terminal domain of the YdhK protein of unknown function from B. subtilis. The
structure of YdhK (PDB accession number 4MDW; Fig. S6B and C) consists of two small
b-sheet domains that are connected by two long b-strands (b2 and b5) that form a
concave, antiparallel b-sheet that has been designated DUF1541. When the electro-
static surface potential of a 0079 model built on the structure with PDB accession
number 4MDW is displayed (Fig. S6B and C), the surface of the cleft between the
b-sheet domains is highly positive, suggesting that this surface is likely responsible for
the binding DNA observed in the SW and EMSA analyses (Fig. 1 and 3). Of note, it was
demonstrated that the binding region (BR) domain of the MSCRAMM protein PsrP from
Streptococcus pneumoniae interacts with eDNA to promote bacterial aggregation (73).
Interestingly, the BR domain (Fig. S5G) consists of an antiparallel b-sheet that, when
dimerized, forms a split b-barrel-like structure in which the positive interior, concave surface
of the barrel binds DNA. Collectively, the findings for the Csa proteins, 0079, and PsrP
suggest that interactions between eDNA and positively charged, concave b-sheets of
lipoproteins may be a general mechanism for stabilizing bacterial biofilms.
Our discovery of SaeP by the SW blotting approach is of particular significance since
this is an auxiliary lipoprotein that works with the membrane protein SaeQ to control
the SaeRS two-component system function (51), which raises the possibility that SaeP
may have a regulatory function in biofilm formation. While SaeP was predicted to be a
lipoprotein, we confirmed that assignment and demonstrated that the C-terminal
domain faces the extracellular environment (Fig. 4). This C-terminal domain was found
to bind eDNA directly in a pH-dependent manner (Fig. 3), and the expression of SaeP
positively impacted the S. aureus biofilm formation capacity. Interestingly, this pheno-
type was dependent on the availability of eDNA, which, coupled with SaeP localization,
allowed us to infer that membrane-bound lipoproteins may function as anchor points
between the biofilm matrix and the bacterial cell surface. Through further investigation,
the positive impact of SaeP expression on biofilm formation was also linked to its
function as a repressor of the SaeRS system (50). The repression of Nuc activity as a
consequence of SaeP overexpression correlated with increased amounts of higher-
molecular-weight eDNA being associated with the cell surface and biofilm matrix.
Consistent with a regulatory role for SaeP, we found that inactivation of saeP resulted
in elevated nuc expression levels (Fig. 8D) and relieved the bistability phenotype that
we previously demonstrated for nuc expression using the BioFlux device (19). This
observation demonstrates that SaeP modulates SaeRS function and controls the sto-
chastic response normally observed in wild-type strains. Taken together, this raises the
possibility that SaeP may regulate biofilm formation and porosity by modulating the
local availability of high-molecular-weight eDNA.
In this work, we developed a novel SW blotting screen for the discovery of S. aureus
biofilm matrix proteins with DNA-binding activity. Collectively, our findings make a case
for extending the electrostatic net model for S. aureus biofilm formation to include
lipoproteins. These membrane-attached lipoproteins may function as important anchor
points that connect the bacterial cell surface to the biofilm matrix. Although our screen
was limited to S. aureus, our findings should be applicable to many different bacteria
since eDNA is recognized as a structural component of the biofilm matrix for numerous
bacterial species (74–76). Moreover, given that biofilms are implicated in various types
of invasive and chronic infections, our findings suggest that lipoproteins make attrac-
tive targets for novel antibiofilm therapies aimed at disrupting biofilms by interfering
with the interactions between individual bacteria and the biofilm matrix.
MATERIALS AND METHODS
Bacterial strains and growth conditions. Escherichia coli was grown in Luria-Bertani (LB) and S.
aureus was grown in tryptic soy broth (TSB) at 37°C with shaking unless otherwise stated. For a complete
list of strains, see Table 2. The antibiotic concentration for maintenance of E. coli plasmids was
100 mgml21 for ampicillin (Amp) and 50 mg ml21 for kanamycin (Kan). S. aureus plasmids were
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maintained with 10 mgml21 chloramphenicol (Cam) or 10 mgml21 erythromycin (Erm). Bacterial growth
was monitored using a Tecan Infinite M200 plate reader (Tecan, Switzerland).
Recombinant DNA and genetic techniques. Restriction enzymes were obtained from New England
BioLabs (Beverly, MA), and T4 DNA ligase was obtained from Promega Corporation (Madison, WI). The
primers used in this study are listed in Table S2 in the supplemental material and were synthesized at
Integrated DNA Technologies (IDT; Coralville, IA). DNA manipulations were performed in E. coli strain
ER2566 or GM2163 (New England BioLabs). Plasmids from ER2566 were transformed into S. aureus strain
RN4220 by electroporation as previously described (77). Plasmids from GM2163 were electroporated
directly into strain LAC-derived strains as described previously (78). Chromosomal markers were moved
by bacteriophage f11 transduction, and strain constructions were verified by PCR. S. aureus genomic
DNA was isolated using a Puregene DNA purification kit (Qiagen). Plasmid constructs and S. aureus
mutants were confirmed by DNA sequencing at the University of Iowa DNA Core Facility or at the
University of Colorado Barbara Davis Center for Diabetes.
Growth curves. Overnight cultures of strains were diluted 1:100 into 25 ml tryptic soy broth (TSB) in
125-ml flasks and incubated in a 37°C shaker at 225 rpm. At each time point, 200 ml was removed and
placed in a 96-well plate. The optical density at 600 nm (OD600) was measured in a Tecan Infinite M200
plate reader (Tecan, Switzerland).
Construction of strains. (i) DsaeP mutant. Two-step overlap PCR was used to create pJB38-∆saeP.
Regions of 600 bp directly upstream and downstream of saeP were amplified from AH1263 genomic DNA
(79) with primer pairs MJT240/CEF169 and CEF170/CEF171 respectively, where CEF169 and CEF170
contained complementary overlapping regions (Table S2). The PCR products were purified, mixed, and
used as the template for the second round of PCR with primer pair MJT240/CEF171. The 1.2-kb PCR
product was purified, digested with EcoRI and KpnI, and ligated into similarly digested pJB38 (80). The
resulting plasmid was used to construct a markerless ∆saeP strain in the AH1263 background, as
described above, and the strain was named CEF93.
TABLE 2 Strains and plasmids used in this study
Strain Genotype Reference or source
AH1263 USA300 CA-MRSA strain LAC Erms isolate 79
AH1178 Newman 91
AH2900 Newman ∆eap 42
AH2902 Newman ∆eap/pLL39_eap 42
AH1811 LAC (AH1263) hla::erm 43
AH2216 LAC (AH1263) ∆saePQRS 46
CFS22 AH2216/pEPSA5_saeP This study
CFS159 AH2216/pEPSA5 This study
AH2340 E. coli ER2566/pET28a_saeP This study
AH3856 E. coli ER2566/pET28a_0079 This study
AH3858 E. coli ER2566/pET28a_0100 This study
AH3860 E. coli ER2566/pET28a_2354 (dsbA) This study
AH3498 LAC (AH1263) ∆saeP This study
CFS155 LAC (AH1263)/pEPSA5_saeP-T7 This study
CFS227 LAC (AH1263)/pEPSA5_0079-T7 This study
CFS228 LAC (AH1263)/pEPSA5_0100-T7 This study
CFS LAC (AH1263)/pEPSA5_2354 (dsbA)-T7 This study
CFS229 LAC (AH1263)/pEPSA5_0175-T7 This study
CFS230 LAC (AH1263)/pEPSA5_1436-T7 This study
CFS231 LAC (AH1263)/pEPSA5_1478-T7 This study
CFS47 AH2216/pEPSA5_saeP(C133A)-T7 This study
CFS222 AH2216/pEPSA5_saeP(C21A)-T7 This study
CFS210 LAC(AH1263) atl::Tn/pEPSA5_saeP-T7 This study
AH1570 LAC(AH1263)/pCM20
AH3759 LAC(AH1263)/pCM38 (Pnuc_sGFP) This study
AH3760 LAC(AH1263) ∆saeP pCM38 (Pnuc_sGFP) This study
AH4333 LAC(AH1263) nuc::LtrB/pEPSA5_saeP This study
AH4334 LAC(AH1263) nuc::LtrB/pEPSA5_dsbA This study
AH2582 LAC(AH1263) ∆isaB This study
AH3201 LAC(AH1263) eap::erm This study
AH3202 LAC(AH1263) ∆isaB eap::erm This study
AH2183 HG001 53
AH2500 AH2183 ∆isaB This study
AH3513 AH2183 eap::erm This study
AH3514 AH2183 ∆isaB eap::erm This study
AH3611 LAC(AH1263) ∆isaB eap::erm nuc::LtrB This study
AH4791 LAC(AH1263) ∆lpl (∆SAUSA300_0400-0409) This study
AH5275 LAC(AH1263) ∆csa locus I (∆SAUSA300_0100-0103) This study
AH5394 LAC(AH1263) ∆csa locus I ∆lpl ∆csa locus IV This study
AH5409 LAC(AH1263) ∆copL::Tn (∆SAUSA300_0079) This study
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(ii) DisaB mutant. As described above, a two-step overlap PCR was used to create pJB38-∆isaB.
Regions directly upstream and downstream of isaB were amplified from AH1263 genomic DNA with
primer pairs CBR2/5 and CBR3/6, respectively (Table S2). The PCR products were purified, mixed, and
used as the template for the second round of PCR with primer pair CBR5/6. The final PCR product was
purified, digested with EcoRI and KpnI, and ligated into similarly digested pJB38. The resulting plasmid
was used to construct a markerless ∆isaB strain in the AH1263 background, and the strain was named
AH2582.
(iii) Csa deletion mutants. Markerless mutations of genes or gene clusters were introduced using
the temperature-sensitive plasmid pJB38 carrying DNA fragments (;1 kb in size) flanking the region
targeted for deletion. The flanking regions were amplified by Phusion High-Fidelity DNA polymerase
(New England BioLabs) with the primers listed in Table S2. The PCR products and pJB38 were digested
with restriction enzymes, as indicated in Table S2, and subsequently purified with a QIAquick PCR
purification kit (Qiagen, Germany). For the flanking region upstream of the SAUSA300_0410 gene, an
EcoRI site located 51 nucleotides downstream of the start of the cloned flanking region was used for
restriction. After triple ligation of the flanking region pairs with pJB38, the resulting plasmid was
electroporated into E. coli DC10B (78). E. coli cells carrying the plasmid were selected on LB plates
containing 100 mg/ml ampicillin, single colonies were picked, and the presence of the plasmid was
confirmed by PCR using the primers listed in the Table S2. The plasmid was recovered from overnight
cultures of positive clones with a QIAquick Spin miniprep kit (Qiagen, Germany), and the sequence of the
flanking regions was confirmed by in-house sequencing with their respective construction primers and
sequencing primers listed in Table S2. The plasmid was electroporated into the S. aureus target strain,
positive clones carrying pJB38 with the desired flanking regions were selected on tryptic soy agar (TSA)
plates containing 10 mg/ml chloramphenicol (Cam) at 30°C, and the presence of the plasmid was
confirmed by PCR with the primers listed in Table S2. For homologous recombination, positive clones
were streaked on TSA-Cam and incubated at 42°C for 24 h. Cam-resistant colonies were restreaked on
TSA-Cam and incubated at 42°C overnight. Single colonies were picked and incubated in 5 ml TSB at 30°C
and 200 rpm overnight. The resulting overnight cultures were diluted 1:1,000 in TSB and incubated at
30°C and 200 rpm overnight. This was repeated for six consecutive days, and subsequently, dilutions
(1026, 1027, and 1028) were plated on TSA plates containing 200 ng/ml anhydrotetracycline for coun-
terselection and incubated at 30°C overnight. Single colonies were then patched on TSA and TSA-Cam
plates and grown at 30°C overnight. Plasmid loss was indicated by growth on TSA but not TSA-Cam.
Colonies were screened for the desired mutation by PCR with primers located on the S. aureus
chromosome outside of the mutated region (Table S2). Mutation of locus I was achieved by deletion of
the genes SAUSA300_0100 to SAUSA300_0103, mutation of lpl was achieved by deletion of the genes
SAUSA300_0410 to SAUSA300_0419, and mutation of locus IV was achieved by consecutive deletion of the
genes SAUSA300_2429, SAUSA300_2430, and SAUSA300_2424.
(iv) CopL mutant. The transposon mutation for CopL (mutant NE1913) was moved into strain LAC
from the Nebraska Transposon Mutant Library (81) by phage transduction using f11.
Plasmid construction. (i) pSKerm-saePQRS complementation plasmid and C133A. The full sae
operon (saePQRS), including 300 bp upstream of saeP, was amplified from AH1263 genomic DNA using
primers CEF16 and CEF17. The 3.5-kb PCR product was purified by agarose gel electrophoresis, digested
with HindIII and XmaI, and ligated to pSKerm, which had been digested with the same enzymes (49). The
SaeP C133A point mutation was generated using two-step overlap PCR with vector primers (pSKerm
for/pSKerm rev) and complementary mutagenesis primers (CEF27/CEF28). All constructs were confirmed
by sequencing at the University of Iowa DNA Core Facility.
(ii) pEPSA5_SaeP-T7 and point mutants. To construct a protein expression construct of SaeP with
the superoxide dismutase ribosome-binding site and a C-terminal T7 tag, saeP was amplified from
AH1263 genomic DNA using primer pair CEF64/CEF65. The PCR product was digested with EcoRI and
XhoI and ligated to similarly digested pEPSA5 (45). The C21A point mutation was generated using
two-step overlap PCR with vector primers and complementary mutagenesis primers. The 5= fragments
were amplified using pEPSA5_saeP as a template and an upstream vector primer (pEPSA5for2) and
reverse primer containing the alanine substitution (CEF227). The 3= saeP-T7 fragments were amplified
using the same template with forward primers containing alanine substitutions (CEF226) and a down-
stream vector primer (pEPSA5rev). The PCR products were purified, and appropriate upstream and
downstream fragments were mixed in a 1:1 ratio. The mixtures were used as templates for the second
round of PCR with primer pair EPSA5for2/EPSA5rev. Overlap PCR products were purified, digested with
EcoRI and XhoI, and ligated to pEPSA5 that had been digested with the same enzymes. All mutants were
confirmed by sequencing at the University of Iowa DNA Core Facility.
(iii) pEPSA5_DsbA-T7. A C-terminally T7-tagged lipoprotein control was constructed by amplifying
dsbA from AH1263 genomic DNA using primer pair CEF217/CEF218. The PCR product was digested with
EcoRI and XhoI and ligated to a similarly digested pEPSA5.
Southwestern analysis. A screen based on SW blotting techniques typically used for characterizing
protein-DNA interactions was developed to identify proteins capable of interacting with eDNA (71). To
generate protein samples for analysis, biofilm and planktonic cultures of either the wild type or a deletion
mutant were grown overnight. Biofilms were grown in plasma-coated plates as previously described (82),
and planktonic cultures were grown in TSB. Biomass was collected by pelleting planktonic cells or
scraping off biofilm cells, and spent medium was filter sterilized and stored at 220°C until the SW
analysis was performed. Isolation of membrane-associated proteins was conducted as previously de-
scribed (83). Briefly, cells were washed twice with 13 SMM buffer (0.5 M sucrose, 20 mM maleic acid, pH
6.5, 20 mM MgCl2) and then resuspended in SMM buffer containing 10 mg/ml of lysostaphin (AMBI
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Products, Lawrence, NY) and incubated for 1.5 h at 37°C. Protoplasts were harvested by centrifugation
(12,000 3 g for 15 min at 4°C), washed with SMM buffer, and resuspended in 20 mM Tris, pH 8.0.
Protoplasts were lysed by sonication on ice (3 times for 5 min each time, 50% duty) using a Sonifier 450
apparatus (Branson, Danbury, CT). Following centrifugation to remove insoluble cell debris (15,000 3 g
for 20 min at 4°C), the membranes were pelleted by centrifugation at 100,000 3 g for 90 min at 4°C. The
membrane pellets were washed twice with 20 mM Tris, pH 8.0, and resuspended in the same buffer. The
protein concentrations of the samples were determined by the Bradford assay, and equal amounts of
protein were separated by SDS-PAGE using duplicate 4 to 20% nonreducing gradient gels (Bio-Rad
Laboratories, Hercules, CA, USA). One gel was stained with Coomassie for protein band visualization, and
the second gel was incubated in refolding TNDCaMg buffer (10 mM Tris, pH 7.5, 50 mM NaCl, 1 mM
dithiothreitol, 5 mM CaCl2, 5 mM MgCl2) containing 0.9 mM Triton X-100 for two 6-h washes to allow for
protein refolding within the gel. The gel was then incubated for 2 h at room temperature in TNDCaMg
buffer (without Triton X-100) containing 2.5 nM an IRD700-labeled 259-bp dsDNA probe. The probe was
generated from the nanA promoter region (84) using IRD700-labeled primers (IDT, Coralville, IA)
MO122IRD700 and MO123IRD700 and purified by electroelution. Following incubation, both gels (the
Coomassie-stained and IRD700-DNA-probed gels) were imaged using the 700-nm channel of a LI-COR
Odyssey CLx imager (LI-COR, Omaha, NE) and processed using Image Studio software. The Coomassie-
stained and DNA-probed gel images were aligned to identify protein bands with DNA-binding activity.
These bands were excised and analyzed at the University of Iowa Proteomic Facility. Following elution
from the gel, the proteins were digested with trypsin, and the resulting peptides were centrifuged
through a 3-kDa-molecular-wright-cutoff membrane and lyophilized. The tryptic peptides were recon-
stituted and separated with an acetonitrile-water gradient using reversed-phase high-performance liquid
chromatography on a Nanobore C18 column coupled on-line to a high-resolution tandem mass spec-
trometer (MS-MS). Mass spectrometric analyses were conducted on a quadrupole time of flight (Q/TOF)
mass spectrometer (Agilent 6520) with a nanospray ionization source. The mass spectral data were
searched against a library of staphylococcal tryptic peptides using Scaffold (version 4.8.4) proteome
software (Proteome Software, Inc., Portland, OR).
Electromobility shift assays. A portion of each purified lipoprotein was dialyzed into either
Tris-acetate, ethanolamine-CAPSO (3-(cyclohexylamino)-2-hydroxy-1-propanesulfonic acid), or bis-Tris–
ACES (N-(2-acetamido)-2-aminoethanesulfonic acid) pKa-matched buffer systems with NaCl added to
155 mM so that they could be used in electromobility shift assays at pHs 8.0, 9.6, and 6.7, respectively.
For each buffer system, a serial 2-fold dilution series of each lipoprotein (20 to 2.5 mM) was combined
with an IRD700-labeled DNA probe (the same 259-bp probe used for SW analysis) at a final concentration
of 5 nM, incubated for 30 min at room temperature, and then electrophoresed on 1% agarose gels that
had been cast with the appropriate pKa-matched buffer. Following electrophoresis, gels were scanned
using the 700-nm channel on an Odyssey CLx imager (LI-COR, Omaha, NE) and visualized using Image
Studio software.
SCAM. The substituted cysteine accessibility method (SCAM) was performed with S. aureus strain
AH2216 according to previously published methods with minor modifications (52). In brief, overnight
cultures were diluted 1:50 into TSB containing Cam and 0.1% xylose and grown in a 37°C shaker until the
cultures reached an OD600 of 2.0. The cells were pelleted and resuspended to an OD600 of 25 in buffer
A (100 mM HEPES, 250 mM sucrose, 25 mM MgCl2, 0.1 mM KCl, pH 7.5). One set of samples was
pretreated with lysostaphin (AMBI Products) prior to labeling with N●-(3-maleimidylpropionyl)biocytin
(MPB; Invitrogen). The other set of samples were first treated with MPB, followed by incubation with
lysostaphin. Residues exposed to the extracellular milieu label under all conditions, while residues in the
cytoplasm are accessible only following permeabilization of the cells with lysostaphin. Both sets of
samples were solubilized by adding 400 ml T7 binding/wash buffer (4.29 mM Na2HPO4, 1.47 mM KH2PO4,
2.7 mM KCl, 137 mM NaCl, 1% NP-40 substitute, pH 7.3). Labeled SaeP constructs were immunoprecipi-
tated using anti-T7 agarose (Novagen) and eluted with T7 elution buffer (100 mM citric acid, pH 2.2, 0.5%
SDS). To avoid possible aggregation, samples were not boiled following addition of 23 SDS-PAGE
loading buffer containing 5% b-mercaptoethanol before analysis by anti-T7 and Strep-HRP Western
blotting.
Forty-eight-well microtiter biofilm assays. Overnight cultures were diluted 1:500 in TSB containing
0.4% glucose and appropriate antibiotics. Subcultured bacteria were incubated in a 37°C shaker for
30 min prior to inoculating 1 ml per well in a 48-well plate. Xylose was added to the appropriate wells
at the specified concentrations, and the plates were incubated in a 37°C humidified shaker (Stuart SI505;
Techni Inc., Burlington, NJ) at 500 rpm for 24 h, unless specified otherwise. Biofilms were stained by first
aspirating the supernatant from each well using a 26-gauge needle. Nonadherent cells were removed by
washing with 750 ml distilled H2O (dH2O) with a multichannel pipette. To stain the adherent biomass,
500 ml of 0.1% crystal violet was added to each well and the plate was incubated at room temperature
for 10 min. Crystal violet was removed by aspiration, and the biofilms were washed with 750 ml dH2O
with a multichannel pipette. To solubilize the remaining crystal violet, 1 ml isopropanol was added to
each well and the plate was incubated at room temperature for at least 30 min. One hundred microliters
of solubilized crystal violet was mixed with 100 ml of isopropanol in a 96-well plate, and the plate was
read at OD595 in a Tecan Infinite M200 plate reader.
Ninety-six-well microtiter biofilm assays. An overnight culture of AH1263 was diluted 1:500 in TSB
containing 0.4% glucose. Subcultured bacteria were incubated in a 37°C shaker for 30 min prior to
inoculating 200 ml to a 96-well plate. Purified His-SaeP (described below) was added to each well at the
prescribed amount, and the plates were incubated in a 37°C humidified shaker at 500 rpm for 24 h.
Biofilms were stained by first aspirating the supernatant from each well using a 26-gauge needle.
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Nonadherent cells were removed by washing with 200 ml dH2O with a multichannel pipette. To stain the
adherent biomass, 100 ml of 0.1% crystal violet was added to each well and the plate was incubated at
room temperature for 10 min. Crystal violet was removed by aspiration, and the biofilms were washed
with 200 ml dH2O with a multichannel pipette. To solubilize the remaining crystal violet, 200 ml isopro-
panol was added to each well and the plate was incubated at room temperature for at least 30 min. One
hundred fifty microliters of solubilized crystal violet was transferred to a new 96-well plate, and the plate
was read at OD595 in a Tecan Infinite M200 or Tecan Infinite 200Pro plate reader.
Biofilm porosity measurements. Biofilms were grown in grown in 96-well filter plates that used
PVDF membranes with 0.45-mm pores (Agilent). Overnight cultures, grown in TSB, were inoculated at a
ratio of 1:250 into TSB supplemented with 0.6% yeast extract and 0.8% glucose, and 100-ml aliquots were
dispensed into plate wells that had been prefilled with 100-ml aliquots of TSB supplemented with 0.6%
yeast extract and 0.8% glucose and that contained either no methicillin or methicillin at 4 mg/ml, yielding
a final concentration of 2 mg/ml for wells containing methicillin. Identical biofilms were set up in parallel
using standard 96-well microtiter plates. Wells containing only sterile medium were included on the filter
plates in order to provide no-biofilm control wells for porosity measurements. After the plates were
incubated statically for 24 h at 37°C, the standard plates were stained with crystal violet as described
above and the filter plates were used for measuring biofilm porosity. Culture supernatants were removed
by aspiration and 100 ml of buffer (50 mM MES [morpholineethanesulfonic acid], pH 5.5, 150 mM NaCl)
containing either an FITC-isocyanide-dextran (with dextran at a molecular weight of either 4K, 10K, 70K,
or 150K) at 1 mg/ml or 100 ml of MES buffer containing a mixture of bovine serum albumin (BSA; MW,
66 kDa), yeast alcohol dehydrogenase (ANH; MW, 150 kDa), and sweet potato b-amylase (MW, 200 kDa)
at concentrations of 1, 12.5, and 12.5 mg/ml, respectively. The higher concentrations of ADH and
b-amylase were used in order to ensure that the proteins were fully in their tetrameric states. The filter
plates were centrifuged in a swinging-bucket rotor for 45 s at 20 3 g, which resulted in ;5 to 10 ml of
flowthrough in the biofilm plates and ;75 ml of flowthrough in the wells with sterile medium. The
concentrations of FITC-dextran in the biofilm flowthrough fractions were quantified by transferring 5 ml
of flowthrough to 96-well microtiter plates in which the wells had been prefilled with 45 ml of MES buffer
(that did not contain FITC-dextran), which resulted in a sufficient volume to uniformly cover the bottoms
of the wells and a FITC concentration that was still within a linear concentration, as confirmed by
standard curves, when the fluorescence was measured in a Tecan Infinite 200Pro plate reader using a
gain of 100 and excitation and emission wavelengths of 470 nm and 523 nm, respectively. The relative
concentrations of proteins in the biofilm flowthrough fractions were determined by separating the
proteins by SDS-PAGE using 4 to 20% gradient gels (Bio-Rad) and staining with Bio-Safe Coomassie G250
stain (Bio-Rad), followed by integration of band intensities by scanning of the gels at 700 nm using a
LI-COR Odyssey CLx scanner and Image Studio software. Analysis of the flowthrough data was accom-
plished using Excel and Prism software. The approaches of quantifying the flowthrough of both
FITC-dextrans and proteins have distinct and complementary advantages and disadvantages. FITC-
dextrans have the disadvantage that only a single-molecular-weight dextran can be passed through each
well, but the simplicity of the method lends itself to examining large numbers of wells. In contrast, the
use of proteins has the disadvantages of being more cumbersome and having intrinsically higher error
rates due to the increased number of steps in the process; it has the advantage of being able to pass
proteins with multiple molecular weights through the same biofilm. We therefore chose to use both
methodologies to assess biofilm porosity.
Flow cell biofilms. Flow cell biofilms were conducted as previously reported with minor modifica-
tions (50). Briefly, overnight cultures were diluted 1:100 in TSB. Inverted flow cell chambers were
inoculated with 1 ml of the subcultures. Cells were allowed to adhere to the acid-etched glass coverslips
for 1 h at room temperature. Following attachment, flow was initiated at a rate of 3.5 rpm. The biofilm
medium consisted of 2% TSB supplemented with 0.2% glucose and 1 mg/ml of chloramphenicol. For
strains containing pEPSA5 as either the empty vector or the vector expressing lipoprotein, the medium
was supplemented with 1 mg/ml of chloramphenicol and 0.1% xylose. The biofilms were grown at 37°C
for 2.5 days. Live/dead staining was performed on mature biofilms using SYTO9 and propidium iodine at
concentrations of 2.5 mM and 15 mM, respectively (LIVE/DEAD BacLight bacterial viability kit; Invitrogen).
Biofilms were imaged using a Leica scanning confocal laser microscope, and three representative images
were taken for each chamber. Images were processed using the FIJI platform (85), and statistical analysis
was conducted using COMSTAT2 software (86, 87).
Western blotting. Samples were electrophoresed on 15% polyacrylamide gels in a Protean 3 system
(Bio-Rad Laboratories, Hercules, CA, USA). Proteins were transferred to Immobilon-P PVDF membranes
(Millipore) at 170 mA for 1 h. For detection of T7-tagged SaeP proteins, membranes were blocked
overnight at 4°C with 5% milk in Tris-buffered saline (TBS; 20 mM Tris-HCl, pH 7.0, with 137 mM NaCl)
containing 0.05% Tween 20 (TBST). Anti-T7 antibody conjugated to horseradish peroxidase (HRP;
Novagen) was diluted 1:15,000 in 0.05% TBST and incubated with the membranes at room temperature
for 1 h. The membranes were washed five times for 2 min each time with 0.05% TBST. For the detection
of biotinylated proteins from the SCAM assays, the membranes were blocked overnight at 4°C with 3%
bovine serum albumin in 0.05% TBST. After three 10-min washes, the membranes were incubated with
streptavidin-HRP (1 mg/ml; Thermo Scientific) diluted 1:7,500 in 0.05% TBST at room temperature for 1 h.
The membranes were washed three times for 10 min each time with 0.05% TBST. All membranes were
imaged by incubating with the SuperSignal West Pico chemiluminescent substrate (Thermo Scientific) for
1 min and then exposed to X-ray film (Research Products International Corporation).
Cloning and purification of His-tagged lipoproteins. Soluble versions of lipoproteins SaeP
(SAUSA300_0693), SAUSA300_0079, SAUSA300_0100, and DsbA (SAUSA300_2354) lacking the
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N-terminal secretion signal and the Cys residue that would be modified with lipid were overexpressed
in E. coli and purified by Ni-affinity chromatography. The genes were amplified from strain LAC genomic
DNA using Phusion high-fidelity DNA polymerase (New England Biolabs, Ipswich, MA) and the following
pairs of primers: for SaeP, primers CEF43 and CEF44; for SAUAS300_0079, primers 00795 and 00793; for
SAUSA300_0100, primers 01005 and 01003; and for DsbA, primers 23545 and 23543. The PCR products
were digested with NheI-HF and BamHI-HF and ligated using T4 DNA ligase into similarly digested
pET28a that had been treated with shrimp alkaline phosphatase. E. coli expression strain ER2566 was
transformed with the ligations, and positive transformants were confirmed by DNA sequencing and
tested for protein expression. For purification, 2 liters of LB medium containing kanamycin at 50 mg/ml
was inoculated with 5 ml of an overnight culture of the lipoprotein-expressing E. coli strain and grown
at 37°C with shaking at 250 rpm to an OD600 of 0.5 to 0.6. Expression was induced with 1 mM IPTG
(isopropyl-b-D-thiogalactopyranoside), and the flasks were incubated at 30°C for 4 h. Cells were harvested
by centrifugation and resuspended in His-Select resin (Sigma) equilibration buffer (50 mM sodium
phosphate, 300 mM NaCl, 10 mM imidazole, pH 8). Cells were lysed using BugBuster master mix
(Novagen), and the resulting lysates were cleared by centrifugation at 30,000 3 g for 30 min at 4°C before
loading onto columns containing His-Select resin (Sigma). The columns were washed with at least 10
column volumes of equilibration buffer, and proteins were eluted with 2 column volumes of elution
buffer (50 mM sodium phosphate, 300 mM NaCl, 250 mM imidazole, pH 8). The purified proteins were
dialyzed into phosphate-buffered saline (PBS).
Nuc FRET assays on biofilm supernatant. The Nuc Förster resonance energy transfer (FRET) assay
was performed on biofilm supernatants as previously described with minor modifications (50). The FRET
oligonucleotide was diluted to 4 mM in 20 mM Tris, pH 8.0, 10 mM CaCl2. Twenty-five microliters of FRET
substrate was mixed with 25 ml of undiluted biofilm supernatant in a 96-well plate using a multichannel
pipette. Solutions were mixed vigorously while avoiding air bubbles and then immediately read in a
Tecan Infinite M200 plate reader at 552 nm of excitation, 580 nm of emission, and a gain of 100 every
3 s for several minutes. Fluorescence units were plotted versus time, and the plot was fit with a linear fit
to determine the slope, or the rate of the reaction. The FRET assay was repeated four times, and the
number of units per milliliter was calculated.
Nuc prevention/dispersal of SaeP biofilms. Purified nuclease (Worthington Biochemical Corpora-
tion, Lakewood, NJ) was resuspended in double-distilled H2O (ddH2O) at a concentration of 400 U/ml.
Fourfold serial dilutions were performed in ddH2O, and 20 ml of each dilution was added across a 96-well
plate. One concentration of xylose was added across each row containing a dilution series of nuclease,
such that each row had either 0, 0.2%, 0.4%, or 0.6% xylose. Overnight cultures of AH2816 (AH1263/
pEPSA5) and CFS155 (AH1263/pEPSA5_SaeP-T7) were diluted 1:500 in TSB containing 0.4% glucose.
Subcultured bacteria were incubated in a 37°C shaker for 30 min, prior to inoculating 180 ml into each
well of the prepared 96-well plate containing various concentrations of nuclease and xylose. The plates
were incubated in a 37°C shaker at 225 rpm for 24 h. The biofilms were stained as described above (see
“Ninety-six-well microtiter biofilm assays” above).
eDNA isolation assay. Biofilm matrix-associated eDNA was isolated as previously described with
some modifications (56). Overnight cultures were diluted 1:1,000 in TSB supplemented with 0.4%
glucose. Six-well plates were inoculated with 4 ml per well of subcultures, and appropriate amounts of
xylose were added to the wells. The biofilms were grown statically for 16 h in a humidified 37°C shaker.
To collect the biofilms, the supernatant was first aspirated off using a 26-gauge needle. The biofilms were
then removed using a cell scraper and placed into preweighed microcentrifuge tubes, and the biomass
was recorded. The biofilms were resuspended in PBS to 100 mg of biomass/ml. Proteinase K was added
at 5 mg/ml, and samples were incubated at 37°C for 2 h to facilitate eDNA release, as previously reported
(88). Cells were removed through centrifugation, and equal volumes of supernatant were collected.
eDNA was isolated using ethanol precipitation (2.5 volumes of 100% ethanol, 1/10 volume of 3 M sodium
acetate, pH 5.0). eDNA was pelleted by centrifugation and resuspended in 200 ml TE (Tris-EDTA) buffer.
Samples were analyzed using agarose gel electrophoresis and ethidium bromide staining.
BioFlux1000 biofilm assays. A BioFlux1000 microfluidic system (Fluxion Biosciences, Inc., San
Francisco, CA) was used to assess biofilm development as previously described (19). BioFlux1000 48-well
plates were used for all experiments. Biofilm growth channels were primed by adding 200 ml of 50% TSB
to the output wells and using a reverse flow for 5 min at 5.0 dynes/cm2. The TSB in the output wells was
replaced with 300 ml of fresh inoculum made from overnight-grown S. aureus cultures diluted to an
optical density at 600 nm (OD600) of 0.8. Three hundred microliters of fresh TSB was added to the input
wells. The growth channels were then seeded by applying a reverse flow for 2 s at 2.0 dynes/cm2. The
seeded plate was left to incubate on the heated (37°C) stage of the BioFlux1000 system for 1 h to allow
cells to attach to the growing channel walls. Inoculum remaining in the input and the output wells was
aspirated, and 1.3 ml of fresh 50% TSB (with or without 2% xylose for the saeP-overexpressing strain) was
added to the input wells. A forward flow at 0.6 dyne/cm2 was then applied to the channels for 18 h.
Bright-field and epifluorescence images were taken in 5-min intervals for a total of 217 time points. All
epifluorescence images monitoring green fluorescent protein (GFP) expression were acquired using a
fluorescein isothiocyanate (FITC) filter. Acquisition settings for images were kept constant throughout all
experiments (bright-field exposure, 10 ms; FITC exposure, 10 ms).
Quantification of acquired biofilm assay images. Images representative of the phenotypes
recorded were observed and selected using BioFlux Montage software (Fluxion Biosciences, Inc.).
Bright-field and epifluorescence images were calibrated to 0.317712 mM/pixel. For bright-field images, a
threshold was set using the Threshold tool and Slider tool to include all cells within each image while
excluding any background area. The total percentage of area covered within this threshold was
eDNA-Binding Proteins in the Biofilm Matrix ®










































designated as the percentage of biofilm coverage, and these values were plotted over time. For
epifluorescence images, the threshold was set to include all light areas (which were considered to be
fluorescing cells), and the total percentage of the area covered within this threshold was designated as
the percentage of fluorescing cells. These values were also plotted over time. All time points were plotted
in 15-min intervals using GraphPad Prism software (GraphPad Software, La Jolla, CA).
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